Blog

  • ‘True visionary’ theatre school founder Sylvia Young dies age 86 | Theatre

    ‘True visionary’ theatre school founder Sylvia Young dies age 86 | Theatre

    Sylvia Young – the founder of a theatre school, which taught the likes of singer Amy Winehouse, EastEnders actor Adam Woodyatt and James Bond star Lashana Lynch – has been hailed as a “true visionary” after she died age 86.

    Her daughters Alison and Frances Ruffelle said it was with great sadness that they confirmed the death of their mother – who “passed away peacefully” on Wednesday, in a statement posted on the Sylvia Young Agency Instagram account.

    Their statement read: “Our mum was a true visionary, she gave young people from all walks of life the chance to pursue their performing arts skills to the highest standard.

    “Her rare ability to recognise raw talent and encourage all her students contributed to the richness of today’s theatre and music world, even winning herself an Olivier award along the way.

    “She believed hard work with a bit of luck brought success, and she was an example of that herself. She leaves as her legacy a wealth of brilliant performers, a thriving school bearing her name, and a priceless place in the nation’s heart.”

    The Sylvia Young theatre school, which was established in 1972 offering full-time and part-time courses, produced a wide range of stars from singers such as Dua Lipa and Rita Ora, to actors such as Billie Piper and Nicholas Hoult.

    Young’s daughters added: “Above all she leaves the memory of an East End girl who worked hard to achieve her goals, took hold of life, and lived it to the full.

    “Her family were everything to her, her wonderful husband, our dad, Norman, and her grandchildren Eliza, Nat, Felix and Coral, plus her great-grandson, Rex.

    “We share her love with her wide and inclusive family, her friends, her students. You all meant the world to her.

    We will miss her so very much.”

    McFly star Tom Fletcher met his wife, podcaster and presenter Giovanna Fletcher, at the school, which they attended from the age of 13, with Young attending their wedding.

    In a tribute, Giovanna Fletcher posted on Instagram: “My life would not be what it is without Sylvia Young. I remember watching Sylvia on Live And Kicking when I was 12 years old, she was talking about her school and all the fun they had there.

    “I phoned up for a brochure and applied for a scholarship without telling my mum and dad. I didn’t get the scholarship, but I got a place with a ‘deal’ attached because Sylvia wanted me there – something I quickly learned the majority of the 140 students had.”

    She continued: “I loved sitting in Sylvia’s office and watching her work. She was meticulous, she knew what every child was up to and how to get the best out of everyone, she was devoted to helping her kids and I know how much she cared for each of us. Sometimes she cared when others didn’t – helping some incredible talent flourish in the process.”

    In a comment on Young’s daughters’ social media post, actor Bonnie Langford added: “Such sad news, Sylvia was such an inspiring, kind and generous person.

    “She made a difference to so many and will be missed by so many, love to all the family and all those who she made feel were her family. Heartfelt condolences to you Frances and Alison and to Stephen and all the team.”

    Radio presenter Tony Blackburn, who was a friend of Young, also paid tribute in a post on X.

    He said: “So sorry to hear Sylvia Young has passed away, she founded the Sylvia Young theatre school which has been responsible for starting so many careers in TV and theatre.

    “She was a very lovely lady who I have had the privilege of knowing for many years. She will be sadly missed.”

    Young was the subject of an episode of This Is Your Life in 1998, and was appointed an officer of the order of the British empire (OBE) in 2005 for her services to the arts.

    She married Norman Ruffelle in London in 1961, and is the grandmother of singer Eliza Doolittle.

    Continue Reading

  • Metal-based nanomedicines for cancer theranostics | Military Medical Research

  • Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

    Google Scholar 

  • Xia CF, Dong XS, Li H, Cao MM, Sun DQ, He SY, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–90.

    Google Scholar 

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Google Scholar 

  • Lusic H, Grinstaff MW. X-ray-computed tomography contrast agents. Chem Rev. 2013;113(3):1641–66.

    CAS 

    Google Scholar 

  • Koikkalainen J, Rhodius-Meester H, Tolonen A, Barkhof F, Tijms B, Lemstra AW, et al. Differential diagnosis of neurodegenerative diseases using structural MRI data. Neuroimage Clin. 2016;11:435–49.

    Google Scholar 

  • Velikova G, Morden JP, Haviland JS, Emery C, Barrett-Lee P, Earl H, et al. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial. Lancet Oncol. 2023;24(12):1359–74.

    CAS 

    Google Scholar 

  • Lu S, Tian H, Li B, Li L, Jiang H, Gao Y, et al. An ellagic acid coordinated copper-based nanoplatform for efficiently overcoming cancer chemoresistance by cuproptosis and synergistic inhibition of cancer cell stemness. Small. 2024;20(17): e2309215.

    Google Scholar 

  • Ge XG, Fu QR, Su LC, Li Z, Zhang WM, Chen T, et al. Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics. Theranostics. 2020;10(11):4809–21.

    CAS 

    Google Scholar 

  • Liu SE, Jiang YX, Liu PC, Yi Y, Hou DY, Li Y, et al. Single-atom gadolinium nano-contrast agents with high stability for tumor T1 magnetic resonance imaging. ACS Nano. 2023;17(9):8053–63.

    CAS 

    Google Scholar 

  • Liao T, Chen ZY, Kuang Y, Ren Z, Yu WQ, Rao W, et al. Small-size Ti3C2Tx MXene nanosheets coated with metal-polyphenol nanodots for enhanced cancer photothermal therapy and anti-inflammation. Acta Biomater. 2023;159:312–23.

    CAS 

    Google Scholar 

  • Liu Y, Wang YH, Song SY, Zhang HJ. Tumor diagnosis and therapy mediated by metal phosphorus-based nanomaterials. Adv Mater. 2021;33(49): e2103936.

    Google Scholar 

  • Bai X, Wang SQ, Yan XL, Zhou HY, Zhan JH, Liu SJ, et al. Regulation of cell uptake and cytotoxicity by nanoparticle core under the controlled shape, size, and surface chemistries. ACS Nano. 2020;14(1):289–302.

    CAS 

    Google Scholar 

  • Wen W, Wu L, Chen Y, Qi XY, Cao J, Zhang X, et al. Ultra-small Fe3O4 nanoparticles for nuclei targeting drug delivery and photothermal therapy. J Drug Deliv Sci Technol. 2020;58:101782.

    CAS 

    Google Scholar 

  • Luo MC, Yukawa H, Sato K, Tozawa M, Tokunaga M, Kameyama T, et al. Multifunctional magnetic CuS/Gd2O3 nanoparticles for fluorescence/magnetic resonance bimodal imaging-guided photothermal-intensified chemodynamic synergetic therapy of targeted tumors. ACS Appl Mater Interfaces. 2022;14(30):34365–76.

    CAS 

    Google Scholar 

  • Wang M, Chang MY, Chen Q, Wang DM, Li CX, Hou ZY, et al. Au2Pt-PEG-Ce6 nanoformulation with dual nanozyme activities for synergistic chemodynamic therapy/phototherapy. Biomaterials. 2020;252:120093.

    CAS 

    Google Scholar 

  • Alfano M, Alchera E, Sacchi A, Gori A, Quilici G, Locatelli I, et al. A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on a5β1-targeted gold nanorods. J Nanobiotechnology. 2023;21(1):301.

    CAS 

    Google Scholar 

  • Guo WH, Ren YX, Chen Z, Shen GD, Lu YD, Zhou HM, et al. Targeted magnetic resonance imaging/near-infrared dual-modal imaging and ferroptosis/starvation therapy of gastric cancer with peritoneal metastasis. Adv Funct Mater. 2023;33(27):2213921.

    CAS 

    Google Scholar 

  • Li SY, Sun WJ, Luo Y, Gao YP, Jiang XP, Yuan C, et al. Hollow PtCo alloy nanospheres as a high-Z and oxygen generating nanozyme for radiotherapy enhancement in non-small cell lung cancer. J Mater Chem B. 2021;9(23):4643–53.

    CAS 

    Google Scholar 

  • Li L, Qi FL, Guo J, Fan J, Zheng WX, Ghulam M, et al. Photothermal therapy for cancer cells using optically tunable Fe2O3@Au hexagonal nanodisks. J Mater Chem A. 2023;11(39):21365–72.

    CAS 

    Google Scholar 

  • Cao XS, Li MX, Liu QY, Zhao JJ, Lu XH, Wang JW. Inorganic sonosensitizers for sonodynamic therapy in cancer treatment. Small. 2023;19(42):e2303195.

    Google Scholar 

  • Liu Y, Zhao H, Wang SH, Niu R, Bi S, Han WK, et al. A wurster-type covalent organic framework with internal electron transfer-enhanced catalytic capacity for tumor therapy. J Am Chem Soc. 2024;146(40):27345–61.

    CAS 

    Google Scholar 

  • Cao SJ, Long YP, Xiao ST, Deng YT, Ma L, Adeli M, et al. Reactive oxygen nanobiocatalysts: activity-mechanism disclosures, catalytic center evolutions, and changing states. Chem Soc Rev. 2023;52(19):6838–81.

    CAS 

    Google Scholar 

  • Liu YY, Zhang M, Bu WB. Bioactive nanomaterials for ion-interference therapy. View. 2020;1(2):e18.

    Google Scholar 

  • Li JX, Ren H, Zhang YM. Metal-based nano-vaccines for cancer immunotherapy. Coord Chem Rev. 2022;455:214345.

    CAS 

    Google Scholar 

  • Yang J, Dai DH, Zhang X, Teng LS, Ma LJ, Yang YW. Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy. Theranostics. 2023;13(1):295–323.

    CAS 

    Google Scholar 

  • Ding JY, He ZJ, Zhai YJ, Ye L, Ji JB, Yang XY, et al. Advances in metal-based nano drugs and diagnostic probes for tumor. Coord Chem Rev. 2024;501:215594.

    CAS 

    Google Scholar 

  • Zhang JJ, Wang XF, Wen J, Su XD, Weng LX, Wang CY, et al. Size effect of mesoporous organosilica nanoparticles on tumor penetration and accumulation. Biomater Sci. 2019;7(11):4790–9.

    CAS 

    Google Scholar 

  • Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014.

    CAS 

    Google Scholar 

  • Dawi EA, Ismail AH, Abdelkader A, Karar AA. Sputtering of size-tunable oxidized Fe nanoparticles by gas flow method. Appl Phys A Mater Sci Process. 2020;126(4):316.

    CAS 

    Google Scholar 

  • Zhao PY, Gao XF, Zhao B, Wang SB, Zhang D, Wu X, et al. Investigation on nano-grinding process of GaN using molecular dynamics simulation: nano-grinding parameters effect. J Manuf Process. 2023;102:429–42.

    Google Scholar 

  • Liu L, Wang SZ, Zhang BQ, Jiang GY, Yang JQ. Supercritical hydrothermal synthesis of nano-ZrO2: influence of technological parameters and mechanism. J Alloy Compd. 2022;898:162878.

    CAS 

    Google Scholar 

  • Fu SY, Yang RH, Ren JJ, Liu JH, Zhang L, Xu ZG, et al. Catalytically active CoFe2O4 nanoflowers for augmented sonodynamic and chemodynamic combination therapy with elicitation of robust immune response. ACS Nano. 2021;15(7):11953–69.

    CAS 

    Google Scholar 

  • Liang ZW, Wang YH, Wang JP, Xu T, Ma SL, Liu Q, et al. Multifunctional Fe3O4-PEI@HA nanoparticles in the ferroptosis treatment of hepatocellular carcinoma through modulating reactive oxygen species. Colloids Surf B Biointerfaces. 2023;227:113358.

    CAS 

    Google Scholar 

  • Caraballo-Vivas RJ, Santos ECS, Valente-Rodrigues CL, Checca NR, Garcia F. Tuning between composition and nanoparticle size of manganites for self-regulated magnetic hyperthermia applications. J Phys D Appl Phys. 2023;56(25):255001.

    CAS 

    Google Scholar 

  • Anitha S, Muthukumaran S. Structural, optical and antibacterial investigation of La, Cu dual doped ZnO nanoparticles prepared by co-precipitation method. Mater Sci Eng C Mater Biol Appl. 2020;108:110387.

    CAS 

    Google Scholar 

  • Gholizadeh Z, Aliannezhadi M, Ghominejad M, Tehrani FS. High specific surface area γ-Al2O3 nanoparticles synthesized by facile and low-cost co-precipitation method. Sci Rep. 2023;13(1):6131.

    CAS 

    Google Scholar 

  • Deng H, Xu H, Zhou JZ, Tang DS, Yang WQ, Hu M, et al. Multi-element imaging of urinary stones by LA-ICP-MS with a homogeneous co-precipitation CaC2O4-matrix calibration standard. Anal Bioanal Chem. 2023;415(9):1751–64.

    CAS 

    Google Scholar 

  • Alemayehu A, Zakharanka A, Tyrpekl V. Homogeneous precipitation of lanthanide oxalates. ACS Omega. 2022;7(14):12288–95.

    CAS 

    Google Scholar 

  • Wu KJ, Tse ECM, Shang CX, Guo ZX. Nucleation and growth in solution synthesis of nanostructures-from fundamentals to advanced applications. Prog Mater Sci. 2022;123:100821.

    CAS 

    Google Scholar 

  • Lunin AV, Kolychev EL, Mochalova EN, Cherkasov VR, Nikitin MP. Synthesis of highly-specific stable nanocrystalline goethite-like hydrous ferric oxide nanoparticles for biomedical applications by simple precipitation method. J Colloid Interface Sci. 2019;541:143–9.

    CAS 

    Google Scholar 

  • Sivakumar S, Venkatesan A, Soundhirarajan P, Khatiwada CP. Synthesis, characterizations and anti-bacterial activities of pure and Ag doped CdO nanoparticles by chemical precipitation method. Spectrochim Acta A Mol Biomol Spectrosc. 2015;136 Pt C:1751–9.

    CAS 

    Google Scholar 

  • Liu J, Li L, Zhang B, Xu ZP. MnO2-shelled doxorubicin/curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy. J Colloid Interface Sci. 2022;617:315–25.

    CAS 

    Google Scholar 

  • Zhang LF, Lu H, Tang Y, Lu XJ, Zhang ZD, Zhang Y, et al. Calcium-peroxide-mediated cascades of oxygen production and glutathione consumption induced efficient photodynamic and photothermal synergistic therapy. J Mater Chem B. 2023;11(13):2937–45.

    CAS 

    Google Scholar 

  • Abadi B, Hosseinalipour S, Nikzad S, Pourshaikhali S, Fathalipour-Rayeni H, Shafiei G, et al. Capping agents for selenium nanoparticles in biomedical applications. J Clust Sci. 2023;34(4):1669–90.

    CAS 

    Google Scholar 

  • Bleier GC, Watt J, Simocko CK, Lavin JM, Huber DL. Reversible magnetic agglomeration: a mechanism for thermodynamic control over nanoparticle size. Angew Chem Int Ed Engl. 2018;57(26):7678–81.

    CAS 

    Google Scholar 

  • Taheri-Ledari R, Salehi MM, Esmailzadeh F, Mohammadi A, Kashtiaray A, Maleki A. A brief survey of principles of co-deposition method as a convenient procedure for preparation of metallic nanomaterials. J Alloy Compd. 2024;980: 173509.

    CAS 

    Google Scholar 

  • Pezeshk-Fallah H, Yari H, Mahdavian M, Ramezanzadeh B. Size/porosity-controlled zinc-based nanoporous-crystalline metal-organic frameworks for application in a high-performance self-healing epoxy coating. Prog Org Coat. 2023;183:107814.

    CAS 

    Google Scholar 

  • Darwish MSA, Kim H, Lee H, Ryu C, Lee JY, Yoon J. Synthesis of magnetic ferrite nanoparticles with high hyperthermia performance via a controlled co-precipitation method. Nanomaterials (Basel). 2019;9(8):1176.

    CAS 

    Google Scholar 

  • Darwish MSA, Al-Harbi LM, Bakry A. Synthesis of magnetite nanoparticles coated with polyvinyl alcohol for hyperthermia application. J Therm Anal Calorim. 2022;147(21):11921–30.

    CAS 

    Google Scholar 

  • Chin YC, Yang LX, Hsu FT, Hsu CW, Chang TW, Chen HY, et al. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation. J Nanobiotechnology. 2022;20(1):373.

    CAS 

    Google Scholar 

  • Hachem K, Ansari MJ, Saleh RO, Kzar HH, Al-Gazally ME, Altimari US, et al. Methods of chemical synthesis in the synthesis of nanomaterial and nanoparticles by the chemical deposition method: a review. BioNanoScience. 2022;12(3):1032–57.

    Google Scholar 

  • Yu ZF, He YY, Schomann T, Wu KF, Hao Y, Suidgeest E, et al. Achieving effective multimodal imaging with rare-earth ion-doped CaF2 nanoparticles. Pharmaceutics. 2022;14(4):840.

    CAS 

    Google Scholar 

  • Thendral KT, Amutha M, Ragunathan R. Design and development of copper cobaltite (CuCo2O4) nanoparticle for antibacterial anticancer and photocatalytic activity. Mater Lett. 2023;349:134720.

    Google Scholar 

  • Fakhraian H, Nassimi A, Javadi N. Reinvestigating the synthesis and properties of high energetic MOFs based on 5,5′-bistetrazole-1,1′-diolate (BTO2-) and some transition metal cations (Pb2+, Cu2+and Ag+). Inorg Chim Acta. 2023;553:121520.

    CAS 

    Google Scholar 

  • He N, Zhu XL, Liu FX, Yu R, Xue ZH, Liu XH. Rational design of FeS2-encapsulated covalent organic frameworks as stable and reusable nanozyme for dual-signal detection glutathione in cell lysates. Chem Eng J. 2022;445:136543.

    CAS 

    Google Scholar 

  • Supriya S, Das S, Senapati S, Naik R. One-pot hydrothermal synthesis of Cu2Te/NiTe nanocomposite materials: a structural, morphological, and optical study. J Am Ceram Soc. 2023;106(10):5955–64.

    CAS 

    Google Scholar 

  • Wijakmatee T, Shimoyama Y, Orita Y. Systematically designed surface and morphology of magnetite nanoparticles using monocarboxylic acid with various chain lengths under hydrothermal condition. Langmuir. 2023;39(26):9253–61.

    CAS 

    Google Scholar 

  • Wang XB, Cheng Y, Han XQ, Yan J, Wu YY, Song PP, et al. Functional 2D iron-based nanosheets for synergistic immunotherapy, phototherapy, and chemotherapy of tumor. Adv Healthc Mater. 2022;11(19):e2200776.

    Google Scholar 

  • Ul Hassan SM, Akram W, Saifullah A, Khurshid A, Ali Z, Shahzad F, et al. Novel PEGylated ZnO nanoparticles with optimized Y dopant exhibiting PL imaging, PDT and CT contrast properties. Mater Lett. 2022;315:131986.

    Google Scholar 

  • Xu ZP, Stevenson GS, Lu CQ, Lu GQM, Bartlett PF, Gray PP. Stable suspension of layered double hydroxide nanoparticles in aqueous solution. J Am Chem Soc. 2006;128(1):36–7.

    CAS 

    Google Scholar 

  • Tong YC, Feng M, Wei JH, Wang DT, Wang QY. One-step synthesis of CoFe2O4 nanomaterials by solvothermal method. Bull Chem Soc Jpn. 2022;95(7):1086–90.

    CAS 

    Google Scholar 

  • Ranoo S, Lahiri BB, Damodaran SP, Philip J. Tuning magnetic heating efficiency of colloidal dispersions of iron oxide nano-clusters by varying the surfactant concentration during solvothermal synthesis. J Mol Liq. 2022;360:119444.

    CAS 

    Google Scholar 

  • Li XJ, Li B, Li R, Yao YZ, Fan N, Qi R, et al. Synthesis of an efficient paramagnetic ZnFe2O4 agent for NIR-I/II responsive photothermal performance. J Alloy Compd. 2023;936:168161.

    CAS 

    Google Scholar 

  • Yeste MP, Fernández-Ponce C, Félix E, Tinoco M, Fernández-Cisnal R, García-Villar C, et al. Solvothermal synthesis and characterization of ytterbium/iron mixed oxide nanoparticles with potential functionalities for applications as multiplatform contrast agent in medical image techniques. Ceram Int. 2022;48(21):31191–202.

    CAS 

    Google Scholar 

  • Asakura Y, Akahira T, Kobayashi M, Osada M, Yin S. Synthesis of NaMoO3F and Na5W3O9F5 with morphological controllability in non-aqueous solvents. Inorg Chem. 2020;59(15):10707–16.

    CAS 

    Google Scholar 

  • Duong HDT, Yoon SH, Nguyen DT, Kim KS. Magnetic heating of water dispersible and size-controlled superparamagnetic cobalt iron oxide nanoparticles. Powder Technol. 2023;427:118720.

    CAS 

    Google Scholar 

  • Duong HDT, Nguyen DT, Kim KS. Effects of process variables on properties of CoFe2O4 nanoparticles prepared by solvothermal process. Nanomaterials (Basel). 2021;11(11):3056.

    CAS 

    Google Scholar 

  • Kelly SN, Russo DR, Arino T, Smith PW, Straub MD, Arnold J, et al. Precursor identity and surfactant concentration influence shape of UO2 nanoparticles. Inorg Chem. 2025;64(16):8117–24.

    CAS 

    Google Scholar 

  • Kim BH, Lee N, Kim H, An K, Park YI, Choi Y, et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. J Am Chem Soc. 2011;133(32):12624–31.

    CAS 

    Google Scholar 

  • Sobhani A, Salavati-Niasari M. Simple synthesis and characterization of nickel phosphide nanostructures assisted by different inorganic precursors. J Mater Sci Mater Electron. 2016;27(4):3619–27.

    CAS 

    Google Scholar 

  • Singapati AY, Ravikumar C. Mechanism of nanoparticle formation in the liquid-phase thermal decomposition method. Langmuir. 2023;39(27):9325–42.

    CAS 

    Google Scholar 

  • Fokina V, Wilke M, Dulle M, Ehlert S, Förster S. Size control of iron oxide nanoparticles synthesized by thermal decomposition methods. J Phys Chem C. 2022;126(50):21356–67.

    CAS 

    Google Scholar 

  • Liu JH, Jin LH, Wang YH, Ding X, Zhang ST, Song SY, et al. A new Co-P nanocomposite with ultrahigh relaxivity for in vivo magnetic resonance imaging-guided tumor eradication by chemo/photothermal synergistic therapy. Small. 2018;14(7):1702431.

    Google Scholar 

  • Dong PL, Zhang TT, Xiang HJ, Xu X, Lv YH, Wang Y, et al. Controllable synthesis of exceptionally small-sized superparamagnetic magnetite nanoparticles for ultrasensitive MR imaging and angiography. J Mater Chem B. 2021;9(4):958–68.

    CAS 

    Google Scholar 

  • Demessie AA, Park Y, Singh P, Moses AS, Korzun T, Sabei FY, et al. An advanced thermal decomposition method to produce magnetic nanoparticles with ultrahigh heating efficiency for systemic magnetic hyperthermia. Small Methods. 2022;6(12):e2200916.

    Google Scholar 

  • Feld A, Weimer A, Kornowski A, Winckelmans N, Merkl JP, Kloust H, et al. Chemistry of shape-controlled iron oxide nanocrystal formation. ACS Nano. 2019;13(1):152–62.

    CAS 

    Google Scholar 

  • Daneshmand-Jahromi S, Sedghkerdar MH, Mahinpey N. Synthesis, characterization, and kinetic study of nanostructured copper-based oxygen carrier supported on silica and zirconia aerogels in the cyclic chemical looping combustion process. Chem Eng J. 2022;448:137756.

    CAS 

    Google Scholar 

  • An SY. Characterization of mossbauer and superparamagnetic properties in maghemite nanoparticles synthesized by a sol-gel method. J Electron Mater. 2023;52(9):6308–15.

    CAS 

    Google Scholar 

  • Miranda-López MI, Contreras-Torres FF, Cavazos-Cavazos D, Martínez-Ortiz PF, Pineda-Aguilar N, Hernández MB, et al. Crystal evolution of nano-sized CoCr2O4 synthesized by a modified sol-gel method. J Phys Chem Solids. 2023;178:111315.

    Google Scholar 

  • Danks AE, Hall SR, Schnepp Z. The evolution of “sol-gel” chemistry as a technique for materials synthesis. Mater Horizons. 2016;3(2):91–112.

    CAS 

    Google Scholar 

  • Sumida K, Liang K, Reboul J, Ibarra IA, Furukawa S, Falcaro P. Sol-gel processing of metal-organic frameworks. Chem Mat. 2017;29(7):2626–45.

    CAS 

    Google Scholar 

  • Arya S, Mahajan P, Mahajan S, Khosla A, Datt R, Gupta V, et al. Review-influence of processing parameters to control morphology and optical properties of sol-gel synthesized ZnO nanoparticles. ECS J Solid State Sci Technol. 2021;10(2):023002.

    CAS 

    Google Scholar 

  • Yang C, Su ZL, Wang YS, Fan HL, Liang MS, Chen ZH. Insight into the effect of gel drying temperature on the structure and desulfurization performance of ZnO/SiO2 adsorbents. Chin J Chem Eng. 2023;56:233–41.

    CAS 

    Google Scholar 

  • Lal M, Sharma P, Ram C. Calcination temperature effect on titanium oxide (TiO2) nanoparticles synthesis. Optik. 2021;241:166934.

    CAS 

    Google Scholar 

  • Rodríguez-Barajas N, Becerra-Solano L, Gutiérrez-Mercado YK, Macías-Carballo M, Gómez CM, Pérez-Larios A. Study of the interaction of Ti-Zn as a mixed oxide at different pH values synthesized by the sol-gel method and its antibacterial properties. Nanomaterials (Basel). 2022;12(12):1948.

    Google Scholar 

  • Sheikhi S, Aliannezhadi M, Tehrani FS. Effect of precursor material, pH, and aging on ZnO nanoparticles synthesized by one-step sol-gel method for photodynamic and photocatalytic applications. Eur Phys J Plus. 2021;137(1):60.

    Google Scholar 

  • Xu N, Hu A, Pu XM, Li JF, Wang XM, Wang J, et al. Fe(III)-chelated polydopamine nanoparticles for synergistic tumor therapies of enhanced photothermal ablation and antitumor immune activation. ACS Appl Mater Interfaces. 2022;14(14):15894–910.

    CAS 

    Google Scholar 

  • Tavakol M, Hajipour MJ, Ferdousi M, Zanganeh S, Maurizi L. Competition of opsonins and dysopsonins on the nanoparticle surface. Nanoscale. 2023;15(43):17342–9.

    CAS 

    Google Scholar 

  • Grundler J, Whang C-H, Shin K, Savan NA, Zhong M, Saltzman WM. Modifying the backbone chemistry of PEG-based bottlebrush block copolymers for the formation of long-circulating nanoparticles. Adv Healthc Mater. 2024;13(22):e2304040.

    Google Scholar 

  • Deng Y, Huang F, Zhang J, Liu J, Li B, Ouyang RZ, et al. PEGylated iridium-based nano-micelle: self-assembly, selective tumor fluorescence imaging and photodynamic therapy. Dyes Pigment. 2020;182:108651.

    CAS 

    Google Scholar 

  • Shi LW, Zhang JQ, Zhao M, Tang SK, Cheng X, Zhang WY, et al. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021;13(24):10748–64.

    CAS 

    Google Scholar 

  • Dubey R, Shende P. Potential of brush and mushroom conformations in biomedical applications. Chem Pap. 2024;78(12):6873–89.

    CAS 

    Google Scholar 

  • Tian XS, Yuan YM. Impacts of polyethylene glycol (PEG) dispersity on protein adsorption, pharmacokinetics, and biodistribution of PEGylated gold nanoparticles. RSC Adv. 2024;14(29):20757–64.

    CAS 

    Google Scholar 

  • Wan Q, Yuan HM, Cai P, Liu Y, Yan T, Wang L, et al. Effects of PEGylation on imaging contrast of 68Ga-labeled bicyclic peptide PET probes targeting nectin-4. Mol Pharm. 2024;21(9):4430–40.

    CAS 

    Google Scholar 

  • Wang XW, Zhong XY, Cheng L. Titanium-based nanomaterials for cancer theranostics. Coord Chem Rev. 2021;430:213662.

    CAS 

    Google Scholar 

  • He Z, Guo YJ, Chen JZ, Luo HL, Liu XX, Zhang XM, et al. Unsaturated phospholipid modified FeOCl nanosheets for enhancing tumor ferroptosis. J Mater Chem B. 2023;11(9):1891–903.

    CAS 

    Google Scholar 

  • Sindhwani S, Syed AM, Ngai J, Kingston BR, Maiorino L, Rothschild J, et al. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19(5):566–75.

    CAS 

    Google Scholar 

  • Liu N, Tang M. Toxic effects and involved molecular pathways of nanoparticles on cells and subcellular organelles. J Appl Toxicol. 2020;40(1):16–36.

    Google Scholar 

  • Yu FF, Wang TY, Wang YH, Liu TF, Xiong HJ, Liu L, et al. Nanozyme-nanoclusters in metal-organic framework: GSH triggered Fenton reaction for imaging guided synergistic chemodynamic-photothermal therapy. Chem Eng J. 2023;472:144910.

    CAS 

    Google Scholar 

  • Yu J, He XD, Zhang QF, Zhou DF, Wang ZG, Huang YB. Iodine conjugated Pt(IV) nanoparticles for precise chemotherapy with iodine-Pt guided computed tomography imaging and biotin-mediated tumor-targeting. ACS Nano. 2022;16(4):6835–46.

    CAS 

    Google Scholar 

  • Meng XQ, Fan HZ, Chen L, He JY, Hong CY, Xie JY, et al. Ultrasmall metal alloy nanozymes mimicking neutrophil enzymatic cascades for tumor catalytic therapy. Nat Commun. 2024;15(1):1626.

    CAS 

    Google Scholar 

  • Qin RX, Li S, Qiu YW, Feng YS, Liu YQ, Ding DD, et al. Carbonized paramagnetic complexes of Mn (II) as contrast agents for precise magnetic resonance imaging of sub-millimeter-sized orthotopic tumors. Nat Commun. 2022;13(1):1938.

    CAS 

    Google Scholar 

  • Wang Z, Xing HY, Liu AN, Guan L, Li XC, He L, et al. Multifunctional nano-system for multi-mode targeted imaging and enhanced photothermal therapy of metastatic prostate cancer. Acta Biomater. 2023;166:581–92.

    CAS 

    Google Scholar 

  • Liu DL, Li JJ, Wang CB, An L, Lin JM, Tian QW, et al. Ultrasmall Fe@Fe3O4 nanoparticles as T1–T2 dual-mode MRI contrast agents for targeted tumor imaging. Nanomedicine. 2021;32:102335.

    CAS 

    Google Scholar 

  • Withers PJ, Bouman C, Carmignato S, Cnudde V, Grimaldi D, Hagen CK, et al. X-ray computed tomography. Nat Rev Methods Primers. 2021;1(1):18.

    CAS 

    Google Scholar 

  • Lee N, Choi SH, Hyeon T. Nano-sized CT contrast agents. Adv Mater. 2013;25(19):2641–60.

    CAS 

    Google Scholar 

  • Fitzgerald PF, Colborn RE, Edic PM, Lambert JW, Torres AS, Bonitatibus PJ, et al. CT image contrast of high-Z elements: phantom imaging studies and clinical implications. Radiology. 2016;278(3):723–33.

    Google Scholar 

  • Mazloumi M, Van Gompel G, Kersemans V, De Mey J, Buls N. The presence of contrast agent increases organ radiation dose in contrast-enhanced CT. Eur Radiol. 2021;31(10):7540–9.

    CAS 

    Google Scholar 

  • Deng YH, Wang XF, Wu X, Yan P, Liu Q, Wu T, et al. Differential renal proteomics analysis in a novel rat model of iodinated contrast-induced acute kidney injury. Ren Fail. 2023;45(1):2178821.

    Google Scholar 

  • Wu JJ, Shen JX, Wang WP, Jiang N, Jin HJ, Che XJ, et al. A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium. Ren Fail. 2022;44(1):1345–55.

    Google Scholar 

  • Gamboa P, De Vicente JS, Galán C, Jáuregui I, Segurola A, García-Lirio E, et al. Non-immediate hypersensitivity reactions to iomeprol: diagnostic value of skin tests and cross-reactivity with other iodinated contrast media. Allergy. 2022;77(12):3641–7.

    Google Scholar 

  • Cruje C, Dunmore-Buyze PJ, Grolman E, Holdsworth DW, Gillies ER, Drangova M. PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT. Sci Rep. 2021;11(1):16603.

    CAS 

    Google Scholar 

  • Ahmed S, Baijal G, Somashekar R, Iyer S, Nayak V. One pot synthesis of PEGylated bimetallic gold-silver nanoparticles for imaging and radiosensitization of oral cancers. Int J Nanomedicine. 2021;16:7103–21.

    CAS 

    Google Scholar 

  • Shariati A, Delavari HH, Poursalehi R. Synthesis and characterization of polydopamine nanoparticles functionalized with hyaluronic acid as a potentially targeted computed tomography contrast agent. BioNanoScience. 2023;13(2):564–75.

    Google Scholar 

  • Asadinezhad M, Azimian H, Ghadiri H, Khademi S. Gold nanoparticle parameters play an essential role as CT imaging contrast agents. J Nanostruct. 2021;11(4):668–77.

    CAS 

    Google Scholar 

  • Inose T, Oikawa T, Tokunaga M, Yamauchi N, Nakashima K, Kato C, et al. Development of composite nanoparticles composed of silica-coated nanorods and single nanometer-sized gold particles toward a novel X-ray contrast agent. Mater Sci Eng B Adv Funct Solid State Mater. 2020;262:114716.

    CAS 

    Google Scholar 

  • Xu JW, Cheng XJ, Chen FX, Li WJ, Xiao XH, Lai PX, et al. Fabrication of multifunctional polydopamine-coated gold nanobones for PA/CT imaging and enhanced synergistic chemo-photothermal therapy. J Mater Sci Technol. 2021;63:97–105.

    CAS 

    Google Scholar 

  • Guan ZP, Zhang TS, Zhu H, Lyu D, Sarangapani S, Xu QH, et al. Simultaneous imaging and selective photothermal therapy through aptamer-driven Au nanosphere clustering. J Phys Chem Lett. 2019;10(2):183–8.

    CAS 

    Google Scholar 

  • Xu PC, Wang R, Yang WQ, Liu YY, He DS, Ye ZX, et al. A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy. J Nanobiotechnology. 2021;19(1):77.

    CAS 

    Google Scholar 

  • D’hollander A, Vande Velde G, Jans H, Vanspauwen B, Vermeersch E, Jose J, et al. Assessment of the theranostic potential of gold nanostars-a multimodal imaging and photothermal treatment study. Nanomaterials (Basel). 2020;10(11):2112.

    Google Scholar 

  • Dong YC, Hajfathalian M, Maidment PSN, Hsu JC, Naha PC, Si-Mohamed S, et al. Effect of gold nanoparticle size on their properties as contrast agents for computed tomography. Sci Rep. 2019;9(1):14912.

    Google Scholar 

  • Haghighi RR, Chatterjee S, Chatterjee VV, Hosseinipanah S, Tadrisinik F. Dependence of the effective mass attenuation coefficient of gold nanoparticles on its radius. Phys Med. 2022;95:25–31.

    Google Scholar 

  • Wu MH, Zhang YY, Zhang Y, Wu MJ, Wu ML, Wu HY, et al. Tumor angiogenesis targeting and imaging using gold nanoparticle probe with directly conjugated cyclic NGR. RSC Adv. 2018;8(3):1706–16.

    CAS 

    Google Scholar 

  • Ashton JR, Gottlin EB, Patz EF, West JL, Badea CT. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer. PLoS One. 2018;13(11):e0206950.

    Google Scholar 

  • Amato C, Susenburger M, Lehr S, Kuntz J, Gehrke N, Franke D, et al. Dual-contrast photon-counting micro-CT using iodine and a novel bismuth-based contrast agent. Phys Med Biol. 2023;68(13):135001.

    CAS 

    Google Scholar 

  • Zelepukin IV, Ivanov IN, Mirkasymov AB, Shevchenko KG, Popov AA, Prasad PN, et al. Polymer-coated BiOCl nanosheets for safe and regioselective gastrointestinal X-ray imaging. J Control Release. 2022;349:475–85.

    CAS 

    Google Scholar 

  • Xu WJ, Cui P, Happonen E, Leppänen J, Liu LZ, Rantanen J, et al. Tailored synthesis of PEGylated bismuth nanoparticles for X-ray computed tomography and photothermal therapy: one-pot, targeted pyrolysis, and self-promotion. ACS Appl Mater Interfaces. 2020;12(42):47233–44.

    CAS 

    Google Scholar 

  • Shakeri M, Delavari HH, Montazerabadi A, Yourdkhani A. Hyaluronic acid-coated ultrasmall BiOI nanoparticles as a potentially targeted contrast agent for X-ray computed tomography. Int J Biol Macromol. 2022;217:668–76.

    CAS 

    Google Scholar 

  • Bao Q, Zhang Y, Liu XY, Yang T, Yue H, Yang MY, et al. Enhanced cancer imaging and chemo-photothermal combination therapy by cancer-targeting bismuth-based nanoparticles. Adv Opt Mater. 2023;11(11):2201482.

    CAS 

    Google Scholar 

  • Ghazanfari A, Marasini S, Miao X, Park JA, Jung KH, Ahmad MY, et al. Synthesis, characterization, and X-ray attenuation properties of polyacrylic acid-coated ultrasmall heavy metal oxide (Bi2O3, Yb2O3, NaTaO3, Dy2O3, and Gd2O3) nanoparticles as potential CT contrast agents. Colloid Surf A Physicochem Eng Asp. 2019;576:73–81.

    CAS 

    Google Scholar 

  • Tian YL, Yi WH, Shao QY, Ma MH, Bai L, Song RD, et al. Automatic-degradable Mo-doped W18O49 based nanotheranostics for CT/FL imaging guided synergistic chemo/photothermal/chemodynamic therapy. Chem Eng J. 2023;462:142156.

    CAS 

    Google Scholar 

  • Li Y, Younis MH, Wang H, Zhang J, Cai W, Ni D. Spectral computed tomography with inorganic nanomaterials: state-of-the-art. Adv Drug Deliv Rev. 2022;189:114524.

    CAS 

    Google Scholar 

  • Greffier J, Villani N, Defez D, Dabli D, Si-Mohamed S. Spectral CT imaging: technical principles of dual-energy CT and multi-energy photon-counting CT. Diagn Interv Imaging. 2023;104(4):167–77.

    Google Scholar 

  • Lei P, Chen H, Feng C, Yuan X, Xiong ZL, Liu YL, et al. Noninvasive visualization of sub-5 mm orthotopic hepatic tumors by a nanoprobe-mediated positive and reverse contrast-balanced imaging strategy. ACS Nano. 2022;16(1):897–909.

    CAS 

    Google Scholar 

  • Li YH, Tan XX, Wang H, Ji XR, Fu Z, Zhang K, et al. Spectral computed tomography-guided photothermal therapy of osteosarcoma by bismuth sulfide nanorods. Nano Res. 2023;16(7):9885–93.

    CAS 

    Google Scholar 

  • Strange C, Shroff GS, Truong MT, Rohren EM. Pitfalls in interpretation of PET/CT in the chest. Semin Ultrasound CT MR. 2021;42(6):588–98.

    Google Scholar 

  • Ghosh S, Liang Y, Cai W, Chakravarty R. In situ radiochemical doping of functionalized inorganic nanoplatforms for theranostic applications: a paradigm shift in nanooncology. J Nanobiotechnology. 2025;23(1):407.

    CAS 

    Google Scholar 

  • Swidan MM, Abd El-Motaleb M, Sakr TM. Unraveling the diagnostic phase of 99mTc-doped iron oxide nanoprobe in sarcoma bearing mice. J Drug Deliv Sci Technol. 2022;78:103990.

    CAS 

    Google Scholar 

  • Heo GS, Zhao YF, Sultan D, Zhang XH, Detering L, Luehmann HP, et al. Assessment of copper nanoclusters for accurate in vivo tumor imaging and potential for translation. ACS Appl Mater Interfaces. 2019;11(22):19669–78.

    CAS 

    Google Scholar 

  • Shin TJ, Jung W, Ha JY, Kim BH, Kim YH. The significance of the visible tumor on preoperative magnetic resonance imaging in localized prostate cancer. Prostate Int. 2021;9(1):6–11.

    Google Scholar 

  • Stephen ZR, Kievit FM, Zhang MQ. Magnetite nanoparticles for medical MR imaging. Mater Today (Kidlington). 2011;14(7–8):330–8.

    CAS 

    Google Scholar 

  • Jeon M, Halbert MV, Stephen ZR, Zhang MQ. Iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging: fundamentals, challenges, applications, and prospectives. Adv Mater. 2021;33(23):e1906539.

    Google Scholar 

  • Estelrich J, Sánchez-Martín MJ, Busquets MA. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomedicine. 2015;10(1):1727–41.

    CAS 

    Google Scholar 

  • Caravan P, Ellison JJ, Mcmurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev. 1999;99(9):2293–352.

    CAS 

    Google Scholar 

  • Shahid I, Joseph A, Lancelot E. Use of real-life safety data from international pharmacovigilance databases to assess the importance of symptoms associated with gadolinium exposure. Invest Radiol. 2022;57(10):664–73.

    CAS 

    Google Scholar 

  • Ahmad MY, Liu SW, Tegafaw T, Al Saidi AKA, Zhao DJ, Liu Y, et al. Biotin-conjugated poly(acrylic acid)-grafted ultrasmall gadolinium oxide nanoparticles for enhanced tumor imaging. Eur J Inorg Chem. 2023;26(27): e202300430.

    CAS 

    Google Scholar 

  • Dai Y, Wu C, Wang S, Li Q, Zhang M, Li JJ, et al. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent. Nanomedicine. 2018;14(2):547–55.

    CAS 

    Google Scholar 

  • Li JL, Jiang X, Shang LH, Li Z, Yang CL, Luo Y, et al. L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent. Drug Deliv. 2021;28(1):134–43.

    CAS 

    Google Scholar 

  • Yang LJ, Wang LL, Huang GM, Zhang X, Chen LL, Li A, et al. Improving the sensitivity of T1 contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons. Theranostics. 2021;11(14):6966–82.

    CAS 

    Google Scholar 

  • Zeng JF, Jing LH, Hou Y, Jiao MX, Qiao RR, Jia QJ, et al. Anchoring group effects of surface ligands on magnetic properties of Fe3O4 nanoparticles: towards high performance MRI contrast agents. Adv Mater. 2014;26(17):2694–8.

    CAS 

    Google Scholar 

  • Thapa B, Diaz-Diestra D, Beltran-Huarac J, Weiner BR, Morell G. Enhanced MRI T2 relaxivity in contrast-probed anchor-free PEGylated iron oxide nanoparticles. Nanoscale Res Lett. 2017;12(1):312.

    Google Scholar 

  • Soleymani M, Khalighfard S, Khodayari S, Khodayari H, Kalhori MR, Hadjighassem MR, et al. Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells. Sci Rep. 2020;10(1):1695.

    CAS 

    Google Scholar 

  • Rezayan AH, Kheirjou S, Edrisi M, Ardestani MS, Alvandi H. A modified PEG-Fe3O4 magnetic nanoparticles conjugated with D(+)glucosamine (DG): MRI contrast agent. J Inorg Organomet Polym Mater. 2022;32(6):1988–98.

    CAS 

    Google Scholar 

  • Shao HL, Min C, Issadore D, Liong M, Yoon TJ, Weissleder R, et al. Magnetic nanoparticles and microNMR for diagnostic applications. Theranostics. 2012;2(1):55–65.

    CAS 

    Google Scholar 

  • Feng Z, Tang T, Wu TX, Yu XM, Zhang YH, Wang M, et al. Perfecting and extending the near-infrared imaging window. Light Sci Appl. 2021;10(1):197.

    CAS 

    Google Scholar 

  • Zhang X, Wang WL, Su LC, Ge XG, Ye JM, Zhao CY, et al. Plasmonic-fluorescent janus Ag/Ag2S nanoparticles for in situ H2O2-activated NIR-II fluorescence imaging. Nano Lett. 2021;21(6):2625–33.

    CAS 

    Google Scholar 

  • Guan XL, Zhang LY, Lai SJ, Zhang JM, Wei JY, Wang K, et al. Green synthesis of glyco-CuInS2 QDs with visible/NIR dual emission for 3D multicellular tumor spheroid and in vivo imaging. J Nanobiotechnol. 2023;21(1):118.

    CAS 

    Google Scholar 

  • Yong KT, Law WC, Hu R, Ye L, Liu LW, Swihart MT, et al. Nanotoxicity assessment of quantum dots: from cellular to primate studies. Chem Soc Rev. 2013;42(3):1236–50.

    CAS 

    Google Scholar 

  • Awasthi P, An XY, Xiang JJ, Kalva N, Shen YQ, Li CY. Facile synthesis of noncytotoxic PEGylated dendrimer encapsulated silver sulfide quantum dots for NIR-II biological imaging. Nanoscale. 2020;12(9):5678–84.

    CAS 

    Google Scholar 

  • Lian W, Tu DT, Hu P, Song XR, Gong ZL, Chen T, et al. Broadband excitable NIR-II luminescent nano-bioprobes based on CuInSe2 quantum dots for the detection of circulating tumor cells. Nano Today. 2020;35:100943.

    CAS 

    Google Scholar 

  • Chen J, Wang C, Yin Y, Liu R, Meng FX, Wang SS, et al. Upconversion luminescence enhancement and color modulation in Yb3+/Er3+/Ln3+ (Ln = Tm, Ho) tri-doped YF3 microrods. Opt Mater. 2023;140:113839.

    CAS 

    Google Scholar 

  • Auzel F. History of upconversion discovery and its evolution. J Lumines. 2020;223:116900.

    CAS 

    Google Scholar 

  • Yu ZF, He YY, Schomann T, Wu KF, Hao Y, Suidgeest E, et al. Rare-earth-metal (Nd3+, Ce3+ and Gd3+)-doped CaF2: nanoparticles for multimodal imaging in biomedical applications. Pharmaceutics. 2022;14(12):2796.

    CAS 

    Google Scholar 

  • Li RY, Li ZJ, Sun XL, Ji J, Liu L, Gu ZG, et al. Graphene quantum dot-rare earth upconversion nanocages with extremely high efficiency of upconversion luminescence, stability and drug loading towards controlled delivery and cancer theranostics. Chem Eng J. 2020;382:122992.

    Google Scholar 

  • Wang YX, Feng M, Lin B, Peng XR, Wang Z, Lv RC. MET-targeted NIR II luminescence diagnosis and up-conversion guided photodynamic therapy for triple-negative breast cancer based on a lanthanide nanoprobe. Nanoscale. 2021;13(43):18125–33.

    CAS 

    Google Scholar 

  • Zhang ZC, Yang Y, Zhao MY, Lu LF, Zhang F, Fan Y. Tunable and enhanced NIR-II luminescence from heavily doped rare-earth nanoparticles for in vivo bioimaging. ACS Appl Bio Mater. 2022;5(6):2935–42.

    CAS 

    Google Scholar 

  • Chen GY, Shen J, Ohulchanskyy TY, Patel NJ, Kutikov A, Li ZP, et al. (α-NaYbF4:Tm3+)/CaF2 core/shell nanoparticles with efficient near-infrared to near-infrared upconversion for high-contrast deep tissue bioimaging. ACS Nano. 2012;6(9):8280–7.

    CAS 

    Google Scholar 

  • Xu F, Luo W, Abudula A, Wang YY, Sun ZJ. Control and enhancement of upconversion luminescence of NaYF4:Yb,Er nanoparticles with multiplet independent resonance modes in multiplexed metal gratings. J Lumines. 2023;253:119487.

    CAS 

    Google Scholar 

  • Lv RC, Wang YX, Lin B, Peng XR, Liu J, Lü WD, et al. Targeted luminescent probes for precise upconversion/NIR II luminescence diagnosis of lung adenocarcinoma. Anal Chem. 2021;93(11):4984–92.

    CAS 

    Google Scholar 

  • Liang Y, An R, Du PY, Lei PP, Zhang HJ. NIR-activated upconversion nanoparticles/hydrogen-bonded organic framework nanocomposites for NIR-II imaging-guided cancer therapy. Nano Today. 2023;48:101751.

    CAS 

    Google Scholar 

  • Du JY, Yang SS, Qiao YC, Lu HT, Dong HF. Recent progress in near-infrared photoacoustic imaging. Biosens Bioelectron. 2021;191:113478.

    CAS 

    Google Scholar 

  • Li ZF, Zhang C, Zhang X, Sui J, Jin L, Lin LS, et al. NIR-II functional materials for photoacoustic theranostics. Bioconjug Chem. 2022;33(1):67–86.

    CAS 

    Google Scholar 

  • Hou H, Chen LM, He HL, Chen LZ, Zhao ZL, Jin YD. Fine-tuning the LSPR response of gold nanorod-polyaniline core-shell nanoparticles with high photothermal efficiency for cancer cell ablation. J Mater Chem B. 2015;3(26):5189–96.

    CAS 

    Google Scholar 

  • Alchera E, Monieri M, Maturi M, Locatelli I, Locatelli E, Tortorella S, et al. Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods. Photoacoustics. 2022;28:100400.

    Google Scholar 

  • He T, Jiang C, He J, Zhang YF, He G, Wu JYZ, et al. Manganese-dioxide-coating-instructed plasmonic modulation of gold nanorods for activatable duplex-imaging-guided NIR-II photothermal-chemodynamic therapy. Adv Mater. 2021;33(13):e2008540.

    Google Scholar 

  • Zhang Y, Li Y, Li JY, Mu F, Wang J, Shen C, et al. DNA-templated Ag@Pd nanoclusters for NIR-II photoacoustic imaging-guided photothermal-augmented nanocatalytic therapy. Adv Healthc Mater. 2023;12(22):e2300267.

    Google Scholar 

  • Fu QR, Zhu R, Song JB, Yang HH, Chen XY. Photoacoustic imaging: contrast agents and their biomedical applications. Adv Mater. 2019;31(6):e1805875.

    Google Scholar 

  • Gao K, Tu WZ, Yu XJ, Ahmad F, Zhang XN, Wu WJ, et al. W-doped TiO2 nanoparticles with strong absorption in the NIR-II window for photoacoustic/CT dual-modal imaging and synergistic thermoradiotherapy of tumors. Theranostics. 2019;9(18):5214–26.

    CAS 

    Google Scholar 

  • Zhang XS, Wei JS, Chen JW, Cheng K, Zhang F, Ashraf G, et al. A nanoplatform of hollow Ag2S/Ag nanocomposite shell for photothermal and enhanced sonodynamic therapy mediated by photoacoustic and CT imaging. Chem Eng J. 2022;433(Pt 2): 133196.

    CAS 

    Google Scholar 

  • Wang Z, He L, Che ST, Xing HY, Guan L, Yang Z, et al. AuNCs-LHRHa nano-system for FL/CT dual-mode imaging and photothermal therapy of targeted prostate cancer. J Mater Chem B. 2022;10(27):5182–90.

    CAS 

    Google Scholar 

  • Li L, Zhang LY, Wang TT, Wu XT, Ren H, Wang CG, et al. Facile and scalable synthesis of novel spherical Au nanocluster assemblies@polyacrylic acid/calcium phosphate nanoparticles for dual-modal imaging-guided cancer chemotherapy. Small. 2015;11(26):3162–73.

    CAS 

    Google Scholar 

  • Wu J, Liu J, Lin B, Lv RC, Yuan Y, Tao XF. Met-targeted dual-modal MRI/NIR II imaging for specific recognition of head and neck squamous cell carcinoma. ACS Biomater Sci Eng. 2021;7(4):1640–50.

    CAS 

    Google Scholar 

  • Dong XW, Ye J, Wang YH, Xiong HJ, Jiang H, Lu HB, et al. Ultra-small and metabolizable near-infrared Au/Gd nanoclusters for targeted FL/MRI imaging and cancer theranostics. Biosensors (Basel). 2022;12(8):558.

    CAS 

    Google Scholar 

  • Bi SH, Deng ZM, Jiang Q, Jiang MY, Zeng SJ. A H2S-triggered dual-modal second near-infrared/photoacoustic intelligent nanoprobe for highly specific imaging of colorectal cancer. Anal Chem. 2021;93(39):13212–8.

    CAS 

    Google Scholar 

  • Wang Z, Jia T, Sun QQ, Kuang Y, Liu B, Xu MS, et al. Construction of Bi/phthalocyanine manganese nanocomposite for trimodal imaging directed photodynamic and photothermal therapy mediated by 808 nm light. Biomaterials. 2020;228:119569.

    CAS 

    Google Scholar 

  • Shan XR, Chen Q, Yin XY, Jiang CZ, Li TH, Wei SS, et al. Polypyrrole-based double rare earth hybrid nanoparticles for multimodal imaging and photothermal therapy. J Mater Chem B. 2020;8(3):426–37.

    CAS 

    Google Scholar 

  • Xue ZL, Yi ZG, Li XL, Li YB, Jiang MY, Liu HR, et al. Upconversion optical/magnetic resonance imaging-guided small tumor detection and in vivo tri-modal bioimaging based on high-performance luminescent nanorods. Biomaterials. 2017;115:90–103.

    CAS 

    Google Scholar 

  • Lipengolts AA, Finogenova YA, Skribitsky VA, Shpakova KE, Anaki A, Motiei M, et al. CT and MRI imaging of theranostic bimodal Fe3O4@Au nanoparticles in tumor bearing mice. Int J Mol Sci. 2022;24(1):70.

    Google Scholar 

  • Ouyang RZ, Cao PH, Jia PP, Wang H, Zong TY, Dai CY, et al. Bistratal Au@Bi2S3 nanobones for excellent NIR-triggered/multimodal imaging-guided synergistic therapy for liver cancer. Bioact Mater. 2020;6(2):386–403.

    Google Scholar 

  • Men XJ, Chen HB, Sun C, Liu YB, Wang RB, Zhang XJ, et al. Thermosensitive polymer dot nanocomposites for trimodal computed tomography/photoacoustic/fluorescence imaging-guided synergistic chemo-photothermal therapy. ACS Appl Mater Interfaces. 2020;12(46):51174–84.

    CAS 

    Google Scholar 

  • Liu H, Wang R, Gao H, Chen L, Li X, Yu X, et al. Nanoprobes for PET/MR imaging. Adv Therap. 2024;7(2):2300232.

    CAS 

    Google Scholar 

  • Hu XM, Tang YF, Hu YX, Lu F, Lu XM, Wang YQ, et al. Gadolinium-chelated conjugated polymer-based nanotheranostics for photoacoustic/magnetic resonance/NIR-II fluorescence imaging-guided cancer photothermal therapy. Theranostics. 2019;9(14):4168–81.

    CAS 

    Google Scholar 

  • Yamini S, Gunaseelan M, Kumar GA, Singh S, Dannangoda GC, Martirosyan KS, et al. NaGdF4:Yb,Er-Ag nanowire hybrid nanocomposite for multifunctional upconversion emission, optical imaging, MRI and CT imaging applications. Mikrochim Acta. 2020;187(6):317.

    CAS 

    Google Scholar 

  • Taheri-Ledari R, Zarei-Shokat S, Qazi FS, Ghafori-Gorab M, Ganjali F, Kashtiaray A, et al. A mesoporous magnetic Fe3O4/BioMOF-13 with a core/shell nanostructure for targeted delivery of doxorubicin to breast cancer cells. ACS Appl Mater Interfaces. 2025;17(12):17703–17.

    CAS 

    Google Scholar 

  • Sykes EA, Chen J, Zheng G, Chan WCW. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano. 2014;8(6):5696–706.

    CAS 

    Google Scholar 

  • Manzanares D, Ceña V. Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell. Pharmaceutics. 2020;12(4):371.

    CAS 

    Google Scholar 

  • Zhang XY, Wu JR, Williams GR, Yang YB, Niu SW, Qian QQ, et al. Dual-responsive molybdenum disulfide/copper sulfide-based delivery systems for enhanced chemo-photothermal therapy. J Colloid Interface Sci. 2019;539:433–41.

    CAS 

    Google Scholar 

  • Bulatao BP, Nalinratana N, Jantaratana P, Vajragupta O, Rojsitthisak P, Rojsitthisak P. Lutein-loaded chitosan/alginate-coated Fe3O4 nanoparticles as effective targeted carriers for breast cancer treatment. Int J Biol Macromol. 2023;242(Pt 1):124673.

    CAS 

    Google Scholar 

  • Suk JS, Xu QG, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28–51.

    CAS 

    Google Scholar 

  • Goswami U, Dutta A, Raza A, Kandimalla R, Kalita S, Ghosh SS, et al. Transferrin-copper nanocluster-doxorubicin nanoparticles as targeted theranostic cancer nanodrug. ACS Appl Mater Interfaces. 2018;10(4):3282–94.

    CAS 

    Google Scholar 

  • Zhao HX, Li TT, Yao C, Gu Z, Liu CX, Li JH, et al. Dual roles of metal-organic frameworks as nanocarriers for miRNA delivery and adjuvants for chemodynamic therapy. ACS Appl Mater Interfaces. 2021;13(5):6034–42.

    CAS 

    Google Scholar 

  • Jiang H, Wang Q, Li L, Zeng Q, Li HM, Gong T, et al. Turning the old adjuvant from gel to nanoparticles to amplify CD8+ T cell responses. Adv Sci (Weinh). 2017;5(1):1700426.

    Google Scholar 

  • Yu WQ, He XQ, Yang ZH, Yang XT, Xiao W, Liu R, et al. Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis. Biomaterials. 2019;217:119309.

    CAS 

    Google Scholar 

  • Belyaev IB, Zelepukin I, Tishchenko VK, Petriev VM, Trushina DB, Klimentov SM, et al. Nanoparticles based on MIL-101 metal-organic frameworks as efficient carriers of therapeutic 188Re radionuclide for nuclear medicine. Nanotechnology. 2024;35(7):075103.

    CAS 

    Google Scholar 

  • Abdelfattah A, Aboutaleb AE, Abdel-Aal AM, Abdellatif AH, Tawfeek HM, Abdel-Rahman SI. Design and optimization of PEGylated silver nanoparticles for efficient delivery of doxorubicin to cancer cells. J Drug Deliv Sci Technol. 2022;71:103347.

    CAS 

    Google Scholar 

  • Khademi Z, Lavaee P, Ramezani M, Alibolandi M, Abnous K, Taghdisi SM. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells. Carbohydr Polym. 2020;248:116735.

    CAS 

    Google Scholar 

  • Wozniak-Budych MJ, Langer K, Peplinska B, Przysiecka L, Jarek M, Jarzebski M, et al. Copper-gold nanoparticles: fabrication, characteristic and application as drug carriers. Mater Chem Phys. 2016;179:242–53.

    CAS 

    Google Scholar 

  • Oladipo AO, Nkambule TTI, Mamba BB, Msagati TM. The stimuli-responsive properties of doxorubicin adsorbed onto bimetallic Au@Pd nanodendrites and its potential application as drug delivery platform. Mater Sci Eng C Mater Biol Appl. 2020;110:110696.

    CAS 

    Google Scholar 

  • Mukherjee S, Kotcherlakota R, Haque S, Bhattacharya D, Kumar JM, Chakravarty S, et al. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma. Mater Sci Eng C Mater Biol Appl. 2020;108:110375.

    CAS 

    Google Scholar 

  • Alizadeh F, Yaghoobi E, Imanimoghadam M, Ramezani M, Alibolandi M, Abnous K, et al. Targeted delivery of epirubicin to cancerous cell using copper sulphide nanoparticle coated with polyarginine and 5TR1 aptamer. J Drug Target. 2023;31(9):986–97.

    CAS 

    Google Scholar 

  • Li Q, Sun LH, Hou MM, Chen QB, Yang RH, Zhang L, et al. Phase-change material packaged within hollow copper sulfide nanoparticles carrying doxorubicin and chlorin e6 for fluorescence-guided trimodal therapy of cancer. ACS Appl Mater Interfaces. 2019;11(1):417–29.

    CAS 

    Google Scholar 

  • Zhu XY, Gu JL, Wang Y, Li B, Li YS, Zhao WR, et al. Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated release. Chem Commun (Camb). 2014;50(63):8779–82.

    CAS 

    Google Scholar 

  • Abbasi E, Milani M, Aval SF, Kouhi M, Akbarzadeh A, Nasrabadi HT, et al. Silver nanoparticles: synthesis methods, bio-applications and properties. Crit Rev Microbiol. 2016;42(2):173–80.

    CAS 

    Google Scholar 

  • Gurunathan S, Qasim M, Park C, Yoo H, Kim JH, Hong K. Cytotoxic potential and molecular pathway analysis of silver nanoparticles in human colon cancer cells HCT116. Int J Mol Sci. 2018;19(8):2269.

    Google Scholar 

  • Thapa RK, Kim JH, Jeong JN, Shin BS, Choi HG, Yong CS, et al. Silver nanoparticle-embedded graphene oxide-methotrexate for targeted cancer treatment. Colloids Surf B Biointerfaces. 2017;153:95–103.

    CAS 

    Google Scholar 

  • Hongsa N, Thinbanmai T, Luesakul U, Sansanaphongpricha K, Muangsin N. A novel modified chitosan/collagen coated-gold nanoparticles for 5-fluo-rouracil delivery: synthesis, characterization, in vitro drug release studies, anti-inflammatory activity and in vitro cytotoxicity assay. Carbohydr Polym. 2022;277:118858.

    CAS 

    Google Scholar 

  • Li YT, Jin J, Wang DW, Lv JW, Hou K, Liu YL, et al. Coordination-responsive drug release inside gold nanorod@metal-organic framework core-shell nanostructures for near-infrared-induced synergistic chemo-photothermal therapy. Nano Res. 2018;11(6):3294–305.

    CAS 

    Google Scholar 

  • Zhou ZX, Liu XR, Zhu DC, Wang Y, Zhang Z, Zhou XF, et al. Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration. Adv Drug Deliv Rev. 2017;115:115–54.

    CAS 

    Google Scholar 

  • Lin G, Zhang Y, Zhang L, Wang JQ, Tian Y, Cai W, et al. Metal-organic frameworks nanoswitch: toward photo-controllable endo/lysosomal rupture and release for enhanced cancer RNA interference. Nano Res. 2020;13(1):238–45.

    CAS 

    Google Scholar 

  • Rueda-Gensini L, Cifuentes J, Castellanos MC, Puentes PR, Serna JA, Muñoz-Camargo C, et al. Tailoring iron oxide nanoparticles for efficient cellular internalization and endosomal escape. Nanomaterials (Basel). 2020;10(9):1816.

    CAS 

    Google Scholar 

  • Zhao M, Li J, Chen DW, Hu HY. A valid bisphosphonate modified calcium phosphate-based gene delivery system: increased stability and enhanced transfection efficiency in vitro and in vivo. Pharmaceutics. 2019;11(9):468.

    CAS 

    Google Scholar 

  • Song WT, Musetti SN, Huang L. Nanomaterials for cancer immunotherapy. Biomaterials. 2017;148:16–30.

    CAS 

    Google Scholar 

  • Dey A, Manna S, Kumar S, Chattopadhyay S, Saha B, Roy S. Immunostimulatory effect of chitosan conjugated green copper oxide nanoparticles in tumor immunotherapy. Cytokine. 2020;127:154958.

    CAS 

    Google Scholar 

  • Chen SB, Li DD, Du XJ, He XY, Huang MW, Wang Y, et al. Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression. Nano Today. 2020;35:100924.

    CAS 

    Google Scholar 

  • An G, Zheng H, Guo L, Huang J, Yang C, Bai Z, et al. A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects. J Colloid Interface Sci. 2024;662:298–312.

    CAS 

    Google Scholar 

  • Hou YY, Wang Y, Tang Y, Zhou ZX, Tan L, Gong T, et al. Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses. J Control Release. 2020;326:120–30.

    CAS 

    Google Scholar 

  • Liu Y, Niu R, Zhao H, Wang YH, Song SY, Zhang HJ, et al. Single-site nanozymes with a highly conjugated coordination structure for antitumor immunotherapy via cuproptosis and cascade-enhanced T lymphocyte activity. J Am Chem Soc. 2024;146(6):3675–88.

    CAS 

    Google Scholar 

  • Chiang CS, Lin YJ, Lee R, Lai YH, Cheng HW, Hsieh CH, et al. Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy. Nat Nanotechnol. 2018;13(8):746–54.

    CAS 

    Google Scholar 

  • Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.

    CAS 

    Google Scholar 

  • Ouyang B, Poon W, Zhang YN, Lin ZP, Kingston BR, Tavares AJ, et al. The dose threshold for nanoparticle tumour delivery. Nat Mater. 2020;19(12):1362–71.

    CAS 

    Google Scholar 

  • Chen QR, Yuan L, Chou WC, Cheng YH, He CL, Monteiro-Riviere NA, et al. Meta-analysis of nanoparticle distribution in tumors and major organs in tumor-bearing mice. ACS Nano. 2023;17(20):19810–31.

    CAS 

    Google Scholar 

  • Lomax ME, Folkes LK, O’neill P. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol (R Coll Radiol). 2013;25(10):578–85.

    CAS 

    Google Scholar 

  • Gong LY, Zhang YJ, Liu CC, Zhang MZ, Han SX. Application of radiosensitizers in cancer radiotherapy. Int J Nanomedicine. 2021;16:1083–102.

    Google Scholar 

  • Schuemann J, Bagley AF, Berbeco R, Bromma K, Butterworth KT, Byrne HL, et al. Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Phys Med Biol. 2020;65(21):21RM02.

    CAS 

    Google Scholar 

  • Kuncic Z, Lacombe S. Nanoparticle radio-enhancement: principles, progress and application to cancer treatment. Phys Med Biol. 2018;63(2):02TR1.

    Google Scholar 

  • Hua Y, Huang JH, Shao ZH, Luo XM, Wang ZY, Liu JQ, et al. Composition-dependent enzyme mimicking activity and radiosensitizing effect of bimetallic clusters to modulate tumor hypoxia for enhanced cancer therapy. Adv Mater. 2022;34(31):e2203734.

    Google Scholar 

  • Guo XX, Guo ZH, Lu JS, Xie WS, Zhong QZ, Sun XD, et al. All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation. Nanoscale. 2021;13(34):14525–37.

    CAS 

    Google Scholar 

  • Ma NN, Wu FG, Zhang XD, Jiang YW, Jia HR, Wang HY, et al. Shape-dependent radiosensitization effect of gold nanostructures in cancer radiotherapy: comparison of gold nanoparticles, nanospikes, and nanorods. ACS Appl Mater Interfaces. 2017;9(15):13037–48.

    CAS 

    Google Scholar 

  • Dou Y, Guo YY, Li XD, Li X, Wang S, Wang L, et al. Size-tuning ionization to optimize gold nanoparticles for simultaneous enhanced CT imaging and radiotherapy. ACS Nano. 2016;10(2):2536–48.

    CAS 

    Google Scholar 

  • Liu PD, Jin HZ, Guo ZR, Ma J, Zhao J, Li DD, et al. Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma. Int J Nanomedicine. 2016;11:5003–14.

    CAS 

    Google Scholar 

  • Afifi MM, El-Gebaly RH, Abdelrahman IY, Rageh MM. Efficacy of iron-silver bimetallic nanoparticles to enhance radiotherapy. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(12):3647–57.

    CAS 

    Google Scholar 

  • Fu WH, Zhang X, Mei LQ, Zhou RY, Yin WY, Wang Q, et al. Stimuli-responsive small-on-large nanoradiosensitizer for enhanced tumor penetration and radiotherapy sensitization. ACS Nano. 2020;14(8):10001–17.

    CAS 

    Google Scholar 

  • Gupta A, Sood A, Bhardwaj D, Shrimali N, Singhmar R, Chaturvedi S, et al. Functionalized chitosan decorated hafnium oxide@gold core-shell nanoparticles for multimodal cancer therapy. Adv Therap. 2024;7(2):2300165.

    CAS 

    Google Scholar 

  • Bonvalot S, Rutkowski PL, Thariat J, Carrere S, Sunyach MP, Saada E, et al. A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall. Ann Oncol. 2018;29:753.

    Google Scholar 

  • Luchette M, Korideck H, Makrigiorgos M, Tillement O, Berbeco R. Radiation dose enhancement of gadolinium-based AGuIX nanoparticles on HeLa cells. Nanomedicine. 2014;10(8):1751–5.

    CAS 

    Google Scholar 

  • Bort G, Lux F, Dufort S, Crémillieux Y, Verry C, Tillement O. EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: from animal to human with theranostic AGuIX nanoparticles. Theranostics. 2020;10(3):1319–31.

    CAS 

    Google Scholar 

  • Verry C, Dufort S, Villa J, Gavard M, Iriart C, Grand S, et al. Theranostic AGuIX nanoparticles as radiosensitizer: a phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial). Radiother Oncol. 2021;160:159–65.

    CAS 

    Google Scholar 

  • Du Z, Wang X, Zhang X, Gu ZJ, Fu XY, Gan SJ, et al. X-ray-triggered carbon monoxide and manganese dioxide generation based on scintillating nanoparticles for cascade cancer radiosensitization. Angew Chem Int Ed Engl. 2023;62(23):e202302525.

    CAS 

    Google Scholar 

  • Chen JX, Gong MF, Fan YL, Feng J, Han LL, Xin HL, et al. Collective plasmon coupling in gold nanoparticle clusters for highly efficient photothermal therapy. ACS Nano. 2022;16(1):910–20.

    CAS 

    Google Scholar 

  • Zhao SB, Luo YQ, Chang Z, Liu CC, Li T, Gan L, et al. BSA-coated gold nanorods for NIR-II photothermal therapy. Nanoscale Res Lett. 2021;16(1):170.

    CAS 

    Google Scholar 

  • Xie BB, Zhao HC, Shui MJ, Ding YF, Sun C, Wang ZY, et al. Spermine-responsive intracellular self-aggregation of gold nanocages for enhanced chemotherapy and photothermal therapy of breast cancer. Small. 2022;18(30):e2201971.

    Google Scholar 

  • Sun L, Bai HF, Jiang HJ, Zhang P, Li J, Qiao WD, et al. MoS2/LaF3 for enhanced photothermal therapy performance of poorly-differentiated hepatoma. Colloids Surf B Biointerfaces. 2022;214:112462.

    CAS 

    Google Scholar 

  • Gao Q, He X, He L, Lin J, Wang L, Xie Y, et al. Hollow Cu2-xSe-based nanocatalysts for combined photothermal and chemodynamic therapy in the second near-infrared window. Nanoscale. 2023;15(44):17987–95.

    CAS 

    Google Scholar 

  • Li XQ, Cao Y, Xu B, Zhao Y, Zhang TQ, Wang YH, et al. A bimetallic nanozyme with cascade effect for synergistic therapy of cancer. ChemMedChem. 2022;17(8):e202100663.

    CAS 

    Google Scholar 

  • Xiong JS, Bian QH, Lei SJ, Deng YT, Zhao KH, Sun SQ, et al. Bi19S27I3 nanorods: a new candidate for photothermal therapy in the first and second biological near-infrared windows. Nanoscale. 2021;13(10):5369–82.

    CAS 

    Google Scholar 

  • Geng P, Yu N, Macharia DK, Meng RR, Qiu P, Tao C, et al. MOF-derived CuS@Cu-MOF nanocomposites for synergistic photothermal-chemodynamic-chemo therapy. Chem Eng J. 2022;441:135964.

    CAS 

    Google Scholar 

  • Melamed JR, Edelstein RS, Day ES. Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy. ACS Nano. 2015;9(1):6–11.

    CAS 

    Google Scholar 

  • Su Z, Yang Z, Xie L, Dewitt JP, Chen Y. Cancer therapy in the necroptosis era. Cell Death Differ. 2016;23(5):748–56.

    CAS 

    Google Scholar 

  • Zhang YJ, Zhan XL, Xiong J, Peng SS, Huang W, Joshi R, et al. Temperature-dependent cell death patterns induced by functionalized gold nanoparticle photothermal therapy in melanoma cells. Sci Rep. 2018;8(1):8720.

    Google Scholar 

  • Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kedzierska E, Knap-Czop K, et al. Photodynamic therapy: mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098–107.

    Google Scholar 

  • Pashootan P, Saadati F, Fahimi H, Rahmati M, Strippoli R, Zarrabi A, et al. Metal-based nanoparticles in cancer therapy: exploring photodynamic therapy and its interplay with regulated cell death pathways. Int J Pharm. 2024;649:123622.

    CAS 

    Google Scholar 

  • Yaraki MT, Liu B, Tan YN. Emerging strategies in enhancing singlet oxygen generation of nano-photosensitizers toward advanced phototherapy. Nanomicro Lett. 2022;14(1):123.

    CAS 

    Google Scholar 

  • Sun JY, Kormakov S, Liu Y, Huang Y, Wu DM, Yang ZG. Recent progress in metal-based nanoparticles mediated photodynamic therapy. Molecules. 2018;23(7):1704.

    Google Scholar 

  • Yin JC, Wu HN, Wang X, Tian L, Yang RL, Liu LZ, et al. Plasmonic nano-dumbbells for enhanced photothermal and photodynamic synergistic damage of cancer cells. Appl Phys Lett. 2020;116(16):163702.

    CAS 

    Google Scholar 

  • Crous A, Abrahamse H. Effective gold nanoparticle-antibody-mediated drug delivery for photodynamic therapy of lung cancer stem cells. Int J Mol Sci. 2020;21(11):3742.

    CAS 

    Google Scholar 

  • Li ZW, Wang C, Cheng L, Gong H, Yin SN, Gong QF, et al. PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy. Biomaterials. 2013;34(36):9160–70.

    CAS 

    Google Scholar 

  • Yu JT, Li Q, Wei ZX, Fan GL, Wan FY, Tian LL. Ultra-stable MOF@MOF nanoplatform for photodynamic therapy sensitized by relieved hypoxia due to mitochondrial respiration inhibition. Acta Biomater. 2023;170:330–43.

    CAS 

    Google Scholar 

  • Mohseni H, Imanparast A, Salarabadi SS, Sazgarnia A. In vitro evaluation of the intensifying photodynamic effect due to the presence of plasmonic hollow gold nanoshells loaded with methylene blue on breast and melanoma cancer cells. Photodiagnosis Photodyn Ther. 2022;40:103065.

    CAS 

    Google Scholar 

  • Yang YM, Hu Y, Du H, Ren E, Wang HJ. Colloidal plasmonic gold nanoparticles and gold nanorings: shape-dependent generation of singlet oxygen and their performance in enhanced photodynamic cancer therapy. Int J Nanomedicine. 2018;13:2065–78.

    CAS 

    Google Scholar 

  • Buchner M, Calavia PG, Muhr V, Kröninger A, Baeumner AJ, Hirsch T, et al. Photosensitiser functionalised luminescent upconverting nanoparticles for efficient photodynamic therapy of breast cancer cells. Photochem Photobiol Sci. 2019;18(1):98–109.

    CAS 

    Google Scholar 

  • Zhang ZY, Ni DL, Wang F, Yin X, Goel S, German LN, et al. In vitro study of enhanced photodynamic cancer cell killing effect by nanometer-thick gold nanosheets. Nano Res. 2020;13(12):3217–23.

    CAS 

    Google Scholar 

  • Yu Y, Geng JL, Ong EYX, Chellappan V, Tan YN. Bovine serum albulmin protein-templated silver nanocluster (BSA-Ag13): an effective singlet oxygen generator for photodynamic cancer therapy. Adv Healthc Mater. 2016;5(19):2528–35.

    CAS 

    Google Scholar 

  • Sargazi S, Simge ER, Gelen SS, Rahdar A, Bilal M, Arshad R, et al. Application of titanium dioxide nanoparticles in photothermal and photodynamic therapy of cancer: an updated and comprehensive review. J Drug Deliv Sci Technol. 2022;75:103605.

    CAS 

    Google Scholar 

  • Fatima H, Jin ZY, Shao ZP, Chen XJ. Recent advances in ZnO-based photosensitizers: synthesis, modification, and applications in photodynamic cancer therapy. J Colloid Interface Sci. 2022;621:440–63.

    CAS 

    Google Scholar 

  • Pan QL, Li MM, Xiao MC, He YL, Sun GY, Xue T, et al. Semiconductor quantum dots (CdX, X=S, Te, Se) modify titanium dioxide nanoparticles for photodynamic inactivation of leukemia HL60 cancer cells. J Nanomater. 2021;2021:4125350.

    Google Scholar 

  • Yang D, Gulzar A, Yang GX, Gai SL, He F, Dai YL, et al. Au nanoclusters sensitized black TiO2-x nanotubes for enhanced photodynamic therapy driven by near-infrared light. Small. 2017;13(48):1703007.

    Google Scholar 

  • Pan M, Hu DR, Yuan LP, Yu Y, Li YC, Qian ZY. Newly developed gas-assisted sonodynamic therapy in cancer treatment. Acta Pharm Sin B. 2023;13(7):2926–54.

    CAS 

    Google Scholar 

  • Son S, Kim JH, Wang XW, Zhang CL, Yoon SA, Shin J, et al. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev. 2020;49(11):3244–61.

    CAS 

    Google Scholar 

  • Yang FF, Dong J, Li ZF, Wang ZH. Metal-organic frameworks (MOF)-assisted sonodynamic therapy in anticancer applications. ACS Nano. 2023;17(5):4102–33.

    CAS 

    Google Scholar 

  • Wang H, Guo JX, Lin W, Fu Z, Ji XR, Yu B, et al. Open-shell nanosensitizers for glutathione responsive cancer sonodynamic therapy. Adv Mater. 2022;34(15):e2110283.

    Google Scholar 

  • Das M, Pandey V, Jajoria K, Bhatia D, Gupta I, Shekhar H. Glycosylated porphyrin derivatives for sonodynamic therapy: ROS generation and cytotoxicity studies in breast cancer cells. ACS Omega. 2023;9(1):1196–205.

    Google Scholar 

  • Liang S, Deng X, Xu G, Xiao X, Wang M, Guo X, et al. A novel Pt-TiO2 heterostructure with oxygen-deficient layer as bilaterally enhanced sonosensitizer for synergistic chemo-sonodynamic cancer therapy. Adv Funct Mater. 2020;30(13):1908598.

    CAS 

    Google Scholar 

  • Liao HQ, Chen MY, Liao ZP, Luo Y, Chen SJ, Wang L, et al. MnO2-based nanoparticles remodeling tumor micro-environment to augment sonodynamic immunotherapy against breast cancer. Biomater Sci. 2025;13(10):2767–82.

    CAS 

    Google Scholar 

  • Gonçalves KD, Vieira DP, Levy D, Bydlowski SP, Courrol LC. Uptake of silver, gold, and hybrids silver-iron, gold-iron and silver-gold aminolevulinic acid nanoparticles by MCF-7 breast cancer cells. Photodiagnosis Photodyn Ther. 2020;32:102080.

    Google Scholar 

  • Dong ZL, Feng LZ, Hao Y, Li QG, Chen MC, Yang ZJ, et al. Synthesis of CaCO3-based nanomedicine for enhanced sonodynamic therapy via amplification of tumor oxidative stress. Chem. 2020;6(6):1391–407.

    CAS 

    Google Scholar 

  • Zhao YY, Wen M, Yu N, Tao C, Ren Q, Qiu P, et al. Design and synthesis of cancer-cell-membrane-camouflaged hemoporfin-Cu9S8 nanoagents for homotypic tumor-targeted photothermal-sonodynamic therapy. J Colloid Interface Sci. 2023;637:225–36.

    CAS 

    Google Scholar 

  • Sazgarnia A, Shanei A, Eshghi H, Hassanzadeh-Khayyat M, Esmaily H, Shanei MM. Detection of sonoluminescence signals in a gel phantom in the presence of protoporphyrin IX conjugated to gold nanoparticles. Ultrasonics. 2013;53(1):29–35.

    CAS 

    Google Scholar 

  • Sazgarnia A, Shanei A, Meibodi NT, Eshghi H, Nassirli H. A novel nanosonosensitizer for sonodynamic therapy in vivo study on a colon tumor model. J Ultrasound Med. 2011;30(10):1321–9.

    Google Scholar 

  • Deng XY, Guo Y, Zhang XD, Wu W, Wu YL, Jing DD, et al. Film-facilitated formation of ferrocenecarboxylic acid-embedded metal-organic framework nanoparticles for sonodynamic osteosarcoma treatment. Mater Today Chem. 2022;24:100842.

    CAS 

    Google Scholar 

  • Zhang C, Xin L, Li J, Cao J, Sun Y, Wang X, et al. Metal-organic framework (MOF)-based ultrasound-responsive dual-sonosensitizer nanoplatform for hypoxic cancer therapy. Adv Healthc Mater. 2022;11(2):e2101946.

    Google Scholar 

  • Zhao YM, Liu JH, He MT, Dong Q, Zhang L, Xu ZG, et al. Platinum-titania schottky junction as nanosonosensitizer, glucose scavenger, and tumor microenvironment-modulator for promoted cancer treatment. ACS Nano. 2022;16(8):12118–33.

    CAS 

    Google Scholar 

  • Perota G, Zahraie N, Vais RD, Zare MH, Sattarahmady N. Au/TiO2 nanocomposite as a triple-sensitizer for 808 and 650 nm phototherapy and sonotherapy: synergistic therapy of melanoma cancer in vitro. J Drug Deliv Sci Technol. 2022;76:103787.

    CAS 

    Google Scholar 

  • Cao Y, Wu TT, Dai WH, Dong HF, Zhang XJ. TiO2 nanosheets with the Au nanocrystal-decorated edge for mitochondria-targeting enhanced sonodynamic therapy. Chem Mat. 2019;31(21):9105–14.

    CAS 

    Google Scholar 

  • Liu Y, Wang Y, Zhen WY, Wang YH, Zhang ST, Zhao Y, et al. Defect modified zinc oxide with augmenting sonodynamic reactive oxygen species generation. Biomaterials. 2020;251:120075.

    CAS 

    Google Scholar 

  • Guan X, Yin HH, Xu XH, Xu G, Zhang Y, Zhou BG, et al. Tumor metabolism-engineered composite nanoplatforms potentiate sonodynamic therapy via reshaping tumor microenvironment and facilitating electron-hole pairs’ separation. Adv Funct Mater. 2020;30(27):2000326.

    CAS 

    Google Scholar 

  • Wang F, Wang BY, You W, Chen G, You YZ. Integrating Au and ZnO nanoparticles onto graphene nanosheet for enhanced sonodynamic therapy. Nano Res. 2022;15(10):9223–33.

    CAS 

    Google Scholar 

  • Dai C, Zhang SJ, Liu Z, Wu R, Chen Y. Two-dimensional graphene augments nanosonosensitized sonocatalytic tumor eradication. ACS Nano. 2017;11(9):9467–80.

    CAS 

    Google Scholar 

  • Liang S, Xiao X, Bai LX, Liu B, Yuan M, Ma PA, et al. Conferring Ti-based MOFs with defects for enhanced sonodynamic cancer therapy. Adv Mater. 2021;33(18):e2100333.

    Google Scholar 

  • Pan XT, Bai LX, Wang H, Wu QY, Wang HY, Liu S, et al. Metal-organic-framework-derived carbon nanostructure augmented sonodynamic cancer therapy. Adv Mater. 2018;30(23):e1800180.

    Google Scholar 

  • Ma AQ, Chen HQ, Cui YH, Luo ZY, Liang RJ, Wu ZH, et al. Metalloporphyrin complex-based nanosonosensitizers for deep-tissue tumor theranostics by noninvasive sonodynamic therapy. Small. 2019;15(5):e1804028.

    Google Scholar 

  • Yang BW, Chen Y, Shi JL. Nanocatalytic medicine. Adv Mater. 2019;31(39):e1901778.

    Google Scholar 

  • Zhang C, Bu WB, Ni DL, Zhang SJ, Li Q, Yao ZW, et al. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction. Angew Chem Int Ed Engl. 2016;55(6):2101–6.

    CAS 

    Google Scholar 

  • Guan SQ, Liu XJ, Li CL, Wang XY, Cao DM, Wang JX, et al. Intracellular mutual amplification of oxidative stress and inhibition multidrug resistance for enhanced sonodynamic/chemodynamic/chemo therapy. Small. 2022;18(13):e2107160.

    Google Scholar 

  • Jia CY, Guo YX, Wu FG. Chemodynamic therapy via Fenton and Fenton-like nanomaterials: strategies and recent advances. Small. 2022;18(6):e2103868.

    Google Scholar 

  • Liu Y, Zhen WY, Wang YH, Liu JH, Jin LH, Zhang TQ, et al. One-dimensional Fe2P acts as a Fenton agent in response to NIR II light and ultrasound for deep tumor synergetic theranostics. Angew Chem Int Ed Engl. 2019;58(8):2407–12.

    CAS 

    Google Scholar 

  • Liu CZ, Chen YX, Zhao J, Wang Y, Shao YL, Gu ZN, et al. Self-assembly of copper-DNAzyme nanohybrids for dual-catalytic tumor therapy. Angew Chem Int Ed Engl. 2021;60(26):14324–8.

    CAS 

    Google Scholar 

  • Liu Y, Wu JD, Jin YH, Zhen WY, Wang YH, Liu JH, et al. Copper(I) phosphide nanocrystals for in situ self-generation magnetic resonance imaging-guided photothermal-enhanced chemodynamic synergetic therapy resisting deep-seated tumor. Adv Funct Mater. 2019;29(50):1904678.

    CAS 

    Google Scholar 

  • Duan JL, Liao T, Xu XY, Liu Y, Kuang Y, Li C. Metal-polyphenol nanodots loaded hollow MnO2 nanoparticles with a “dynamic protection” property for enhanced cancer chemodynamic therapy. J Colloid Interface Sci. 2023;634:836–51.

    CAS 

    Google Scholar 

  • Sun LN, Cao Y, Li WJ, Wang L, Ding P, Lu ZZ, et al. Perovskite-type manganese vanadate sonosensitizers with biodegradability for enhanced sonodynamic therapy of cancer. Small. 2023;19(27):e2300101.

    Google Scholar 

  • Zhu HJ, Huang SY, Ding MB, Li ZB, Li JC, Wang SH, et al. Sulfur defect-engineered biodegradable cobalt sulfide quantum dot-driven photothermal and chemodynamic anticancer therapy. ACS Appl Mater Interfaces. 2022;14(22):25183–96.

    CAS 

    Google Scholar 

  • Li DY, Ha EN, Zhang JG, Wang LY, Hu JQ. A synergistic chemodynamic-photodynamic-photothermal therapy platform based on biodegradable Ce-doped MoOx nanoparticles. Nanoscale. 2022;14(39):14471–81.

    CAS 

    Google Scholar 

  • Liu QW, Zhang A, Wang RH, Zhang Q, Cui DX. A review on metal- and metal oxide-based nanozymes: properties, mechanisms, and applications. Nanomicro Lett. 2021;13(1):154.

    CAS 

    Google Scholar 

  • Dong SM, Dong YS, Jia T, Liu SK, Liu J, Yang D, et al. GSH-depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy. Adv Mater. 2020;32(42):e2002439.

    Google Scholar 

  • Pan MM, Li PZ, Yu YP, Jiang M, Yang XL, Zhang P, et al. Bimetallic ions functionalized metal-organic-framework nanozyme for tumor microenvironment regulating and enhanced photodynamic therapy for hypoxic tumor. Adv Healthc Mater. 2023;12(26):e2300821.

    Google Scholar 

  • Feng J, Kong F, Yue WS, Yu H, He ZL, Zhai YN, et al. Covalent organic framework-based nanozyme for cascade-amplified synergistic cancer therapy. Sci China Mater. 2023;66(10):4079–89.

    CAS 

    Google Scholar 

  • Zhu YL, Wang Z, Zhao RX, Zhou YH, Feng LL, Gai SL, et al. Pt decorated Ti3C2Tx MXene with NIR-II light amplified nanozyme catalytic activity for efficient phototheranostics. ACS Nano. 2022;16(2):3105–18.

    CAS 

    Google Scholar 

  • Zhang JG, Ha E, Li DY, He SQ, Wang LY, Kuang SL, et al. Dual enzyme-like Co-FeSe2 nanoflowers with GSH degradation capability for NIR II-enhanced catalytic tumor therapy. J Mater Chem B. 2023;11(19):4274–86.

    CAS 

    Google Scholar 

  • Wan X, Zhang H, Yan Q, Hu H, Pan W, Chai Y, et al. Three-dimensional covalent organic frameworks as enzyme nanoprotector: preserving the activity of catalase in acidic environment for hypoxia cancer therapy. Mater Today Nano. 2022;19:100236.

    CAS 

    Google Scholar 

  • Dong SM, Dong YS, Liu B, Liu J, Liu SK, Zhao ZY, et al. Guiding transition metal-doped hollow cerium tandem nanozymes with elaborately regulated multi-enzymatic activities for intensive chemodynamic therapy. Adv Mater. 2022;34(7):e2107054.

    Google Scholar 

  • Liu J, Dong SM, Gai SL, Dong YS, Liu B, Zhao ZY, et al. Design and mechanism insight of monodispersed AuCuPt alloy nanozyme with antitumor activity. ACS Nano. 2023;17(20):20402–23.

    CAS 

    Google Scholar 

  • Wang ZQ, Li GL, Gao Y, Yu Y, Yang P, Li B, et al. Trienzyme-like iron phosphates-based (FePOs) nanozyme for enhanced anti-tumor efficiency with minimal side effects. Chem Eng J. 2021;404:125574.

    CAS 

    Google Scholar 

  • Liu Y, Zhao H, Zhao YL. Designing efficient single metal atom biocatalysts at the atomic structure level. Angew Chem Int Ed Engl. 2024;63(13):e202315933.

    CAS 

    Google Scholar 

  • Zhang SL, Ao X, Huang J, Wei B, Zhai YL, Zhai D, et al. Isolated single-atom Ni-N5 catalytic site in hollow porous carbon capsules for efficient lithium-sulfur batteries. Nano Lett. 2021;21(22):9691–8.

    CAS 

    Google Scholar 

  • Liu Y, Wang B, Zhu JJ, Xu XN, Zhou B, Yang Y. Single-atom nanozyme with asymmetric electron distribution for tumor catalytic therapy by disrupting tumor redox and energy metabolism homeostasis. Adv Mater. 2023;35(9):e2208512.

    Google Scholar 

  • Liu Y, Niu R, Deng RP, Wang YH, Song SY, Zhang HJ. Multi-enzyme co-expressed nanomedicine for anti-metastasis tumor therapy by up-regulating cellular oxidative stress and depleting cholesterol. Adv Mater. 2024;36(2):e2307752.

    Google Scholar 

  • Yu SP, Canzoniero LMT, Choi DW. Ion homeostasis and apoptosis. Curr Opin Cell Biol. 2001;13(4):405–11.

    CAS 

    Google Scholar 

  • Okada Y. Ion channels and transporters involved in cell volume regulation and sensor mechanisms. Cell Biochem Biophys. 2004;41(2):233–58.

    Google Scholar 

  • Jiang W, Yin L, Chen HM, Paschall AV, Zhang LY, Fu WY, et al. NaCl nanoparticles as a cancer therapeutic. Adv Mater. 2019;31(46):e1904058.

    Google Scholar 

  • Ding BB, Sheng JY, Zheng P, Li CX, Li D, Cheng ZY, et al. Biodegradable upconversion nanoparticles induce pyroptosis for cancer immunotherapy. Nano Lett. 2021;21(19):8281–9.

    CAS 

    Google Scholar 

  • Liu Y, Zhen WY, Wang YH, Song SY, Zhang HJ. Na2S2O8 nanoparticles trigger antitumor immunotherapy through reactive oxygen species storm and surge of tumor osmolarity. J Am Chem Soc. 2020;142(52):21751–7.

    CAS 

    Google Scholar 

  • Pardo LA, Stühmer W. The roles of K+ channels in cancer. Nat Rev Cancer. 2014;14(1):39–48.

    CAS 

    Google Scholar 

  • Zhang M, Shen B, Song RX, Wang H, Lv B, Meng XF, et al. Radiation-assisted metal ion interference tumor therapy by barium peroxide-based nanoparticles. Mater Horizons. 2019;6(5):1034–40.

    CAS 

    Google Scholar 

  • Wu Y, Huang P, Dong XP. Lysosomal calcium channels in autophagy and cancer. Cancers (Basel). 2021;13(6):1299.

    CAS 

    Google Scholar 

  • Choi S, Cui CC, Luo YH, Kim SH, Ko JK, Huo XF, et al. Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1. FASEB J. 2018;32(1):404–16.

    CAS 

    Google Scholar 

  • Guo DD, Du YX, Wu QX, Jiang WJ, Bi HS. Disrupted calcium homeostasis is involved in elevated zinc ion-induced photoreceptor cell death. Arch Biochem Biophys. 2014;560:44–51.

    CAS 

    Google Scholar 

  • Ollig J, Kloubert V, Taylor KM, Rink L. B cell activation and proliferation increase intracellular zinc levels. J Nutr Biochem. 2019;64:72–9.

    CAS 

    Google Scholar 

  • Zhang M, Song RX, Liu YY, Yi ZG, Meng XF, Zhang JW, et al. Calcium-overload-mediated tumor therapy by calcium peroxide nanoparticles. Chem. 2019;5(8):2171–82.

    CAS 

    Google Scholar 

  • Johnstone TC, Suntharalingam K, Lippard SJ. Third row transition metals for the treatment of cancer. Philos Trans A Math Phys Eng Sci. 2015;373(2037):20140185.

    Google Scholar 

  • Zheng SZ, Li GT, Shi JB, Liu XY, Li M, He ZG, et al. Emerging platinum(IV) prodrug nanotherapeutics: a new epoch for platinum-based cancer therapy. J Control Release. 2023;361:819–46.

    CAS 

    Google Scholar 

  • Vigna V, Scoditti S, Spinello A, Mazzone G, Sicilia E. Anticancer activity, reduction mechanism and G-quadruplex DNA binding of a redox-activated platinum(IV)-salphen complex. Int J Mol Sci. 2022;23(24):15579.

    CAS 

    Google Scholar 

  • Luo KJ, Guo WX, Yu YT, Xu SM, Zhou M, Xiang KQ, et al. Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo. J Control Release. 2020;326:25–37.

    CAS 

    Google Scholar 

  • Bi HT, Dai YL, Yang PP, Xu JT, Yang D, Gai SL, et al. Glutathione and H2O2 consumption promoted photodynamic and chemotherapy based on biodegradable MnO2-Pt@Au25 nanosheets. Chem Eng J. 2019;356:543–53.

    CAS 

    Google Scholar 

  • Zhou FY, Feng B, Yu HJ, Wang DG, Wang TT, Ma YT, et al. Tumor microenvironment-activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade. Adv Mater. 2019;31(14):e1805888.

    Google Scholar 

  • Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM. Immunogenic cell death in cancer: concept and therapeutic implications. J Transl Med. 2023;21(1):162.

    CAS 

    Google Scholar 

  • Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860–75.

    CAS 

    Google Scholar 

  • Sen S, Won M, Levine MS, Noh Y, Sedgwick AC, Kim JS, et al. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future. Chem Soc Rev. 2022;51(4):1212–33.

    CAS 

    Google Scholar 

  • Liu Y, Wang YH, Song SY, Zhang HJ. Cascade-responsive nanobomb with domino effect for anti-tumor synergistic therapies. Natl Sci Rev. 2022;9(3):nwab139.

    CAS 

    Google Scholar 

  • Niu R, Liu Y, Xu B, Deng RP, Zhou SJ, Cao Y, et al. Programmed targeting pyruvate metabolism therapy amplified single-atom nanozyme-activated pyroptosis for immunotherapy. Adv Mater. 2024;36(24):e2312124.

    Google Scholar 

  • Liu Y, Niu R, Deng RP, Song SY, Wang YH, Zhang HJ. Multi-enzyme co-expressed dual-atom nanozymes induce cascade immunogenic ferroptosis via activating interferon-γ and targeting arachidonic acid metabolism. J Am Chem Soc. 2023;145(16):8965–78.

    CAS 

    Google Scholar 

  • Li J, Wang SJ, Lin XY, Cao YB, Cai ZX, Wang J, et al. Red blood cell-mimic nanocatalyst triggering radical storm to augment cancer immunotherapy. Nanomicro Lett. 2022;14(1):57.

    CAS 

    Google Scholar 

  • Tan X, Huang JZ, Wang YQ, He SS, Jia L, Zhu YH, et al. Transformable nanosensitizer with tumor microenvironment-activated sonodynamic process and calcium release for enhanced cancer immunotherapy. Angew Chem Int Ed Engl. 2021;60(25):14051–9.

    CAS 

    Google Scholar 

  • Ma YC, Zhang YX, Li XQ, Zhao YY, Li M, Jiang W, et al. Near-infrared II phototherapy induces deep tissue immunogenic cell death and potentiates cancer immunotherapy. ACS Nano. 2019;13(10):11967–80.

    CAS 

    Google Scholar 

  • Kaur P, Aliru ML, Chadha AS, Asea A, Krishnan S. Hyperthermia using nanoparticles – promises and pitfalls. Int J Hyperthermia. 2016;32(1):76–88.

    CAS 

    Google Scholar 

  • Pan J, Hu P, Guo YD, Hao JN, Ni DL, Xu YY, et al. Combined magnetic hyperthermia and immune therapy for primary and metastatic tumor treatments. ACS Nano. 2020;14(1):1033–44.

    CAS 

    Google Scholar 

  • Oleszycka E, Lavelle EC. Immunomodulatory properties of the vaccine adjuvant alum. Curr Opin Immunol. 2014;28:1–5.

    CAS 

    Google Scholar 

  • Lv MZ, Chen MX, Zhang R, Zhang W, Wang CG, Zhang Y, et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res. 2020;30(11):966–79.

    CAS 

    Google Scholar 

  • Zhao Z, Ma ZX, Wang B, Guan YK, Su XD, Jiang ZF. Mn2+ directly activates cGAS and structural analysis suggests Mn2+ induces a noncanonical catalytic synthesis of 2′3′-cGAMP. Cell Rep. 2020;32(7):108053.

    CAS 

    Google Scholar 

  • Hou L, Tian CY, Yan YS, Zhang LW, Zhang HJ, Zhang ZZ. Manganese-based nanoactivator optimizes cancer immunotherapy via enhancing innate immunity. ACS Nano. 2020;14(4):3927–40.

    CAS 

    Google Scholar 

  • Sun XQ, Zhang Y, Li JQ, Park KS, Han K, Zhou XW, et al. Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy. Nat Nanotechnol. 2021;16(11):1260–70.

    CAS 

    Google Scholar 

  • Du MJ, Chen ZJJ. DNA-induced liquid phase condensation of cGAS activates innate immune signaling. Science. 2018;361(6403):704–9.

    CAS 

    Google Scholar 

  • Zhang LX, Zhao J, Hu X, Wang CH, Jia YB, Zhu CJ, et al. A peritumorally injected immunomodulating adjuvant elicits robust and safe metalloimmunotherapy against solid tumors. Adv Mater. 2022;34(41):e2206915.

    Google Scholar 

  • Chaigne-Delalande B, Li FY, O’connor GM, Lukacs MJ, Jiang P, Zheng LX, et al. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 2013;341(6142):186–91.

    CAS 

    Google Scholar 

  • Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature. 2011;475(7357):471–6.

    CAS 

    Google Scholar 

  • Kang Y, Xu LL, Dong JR, Huang YZ, Yuan X, Li RY, et al. Calcium-based nanotechnology for cancer therapy. Coord Chem Rev. 2023;481:215050.

    CAS 

    Google Scholar 

  • Tan HZ, Mao KR, Cong XX, Xin YB, Liu FQ, Wang JL, et al. In vivo immune adjuvant effects of CaCO3 nanoparticles through intracellular Ca2+ concentration regulation. ACS Appl Mater Interfaces. 2023;15(33):39157–66.

    CAS 

    Google Scholar 

  • Liu YN, Wei CF, Lin AG, Pan JL, Chen X, Zhu XF, et al. Responsive functionalized MoSe2 nanosystem for highly efficient synergistic therapy of breast cancer. Colloids Surf B Biointerfaces. 2020;189:110820.

    CAS 

    Google Scholar 

  • Qiang SF, Hu XC, Li RH, Wu WJ, Fang K, Li H, et al. CuS nanoparticles-loaded and cisplatin prodrug conjugated Fe(III)-MOFs for MRI-guided combination of chemotherapy and NIR-II photothermal therapy. ACS Appl Mater Interfaces. 2022;14(32):36503–14.

    CAS 

    Google Scholar 

  • Sun HP, Su JH, Meng QS, Yin Q, Chen LL, Gu WW, et al. Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer. Adv Funct Mater. 2017;27(3):1604300.

    Google Scholar 

  • Wu R, Wang HZ, Hai L, Wang TZ, Hou M, He DG, et al. A photosensitizer-loaded zinc oxide-polydopamine core-shell nanotherapeutic agent for photodynamic and photothermal synergistic therapy of cancer cells. Chin Chem Lett. 2020;31(1):189–92.

    CAS 

    Google Scholar 

  • Zhang ST, Jin LH, Liu JH, Liu Y, Zhang TQ, Zhao Y, et al. Boosting chemodynamic therapy by the synergistic effect of co-catalyze and photothermal effect triggered by the second near-infrared light. Nanomicro Lett. 2020;12(1):180.

    Google Scholar 

  • Yang GB, Wang DD, Phua SZF, Bindra AK, Qian C, Zhang R, et al. Albumin-based therapeutics capable of glutathione consumption and hydrogen peroxide generation for synergetic chemodynamic and chemotherapy of cancer. ACS Nano. 2022;16(2):2319–29.

    CAS 

    Google Scholar 

  • Chang YZ, Huang JR, Shi SJ, Xu LG, Lin H, Chen TF. Precise engineering of a Se/Te nanochaperone for reinvigorating cancer radio-immunotherapy. Adv Mater. 2023;35(36):e2212178.

    Google Scholar 

  • Wang DY, Lin SB, Li TW, Yang XH, Zhong X, Chen Q, et al. Cancer cell membrane-coated siRNA-decorated Au/MnO2 nanosensitizers for synergistically enhanced radio-immunotherapy of breast cancer. Mater Today Bio. 2024;29:101275.

    CAS 

    Google Scholar 

  • Liu Y, Zhen WY, Jin LH, Zhang ST, Sun GY, Zhang TQ, et al. All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication. ACS Nano. 2018;12(5):4886–93.

    CAS 

    Google Scholar 

  • Meng NQ, Xu PJ, Wen CC, Liu HH, Gao CJ, Shen XC, et al. Near-infrared-II-activatable sulfur-deficient plasmonic Bi2S3-x-Au heterostructures for photoacoustic imaging-guided ultrasound enhanced high performance phototherapy. J Colloid Interface Sci. 2023;644:437–53.

    CAS 

    Google Scholar 

  • Mo XW, Phan NM, Nguyen TL, Kim J. H2O2 self-supplying CaO2 nanoplatform induces Ca2+ overload combined with chemodynamic therapy to enhance cancer immunotherapy. ACS Appl Mater Interfaces. 2024;16(43):58337–45.

    CAS 

    Google Scholar 

  • Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103(2):317–24.

    Google Scholar 

  • Libutti SK, Paciotti GF, Byrnes AA, Alexander HR, Gannon WE, Walker M, et al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res. 2010;16(24):6139–49.

    CAS 

    Google Scholar 

  • Rasmussen K, Bleeker EJ, Baker J, Bouillard J, Fransman W, Kuhlbusch TJ, et al. A roadmap to strengthen standardisation efforts in risk governance of nanotechnology. NanoImpact. 2023;32:100483.

    CAS 

    Google Scholar 

Continue Reading

  • No plans to stay away from contest for AMMA president post, says actor Devan

    No plans to stay away from contest for AMMA president post, says actor Devan

    Senior actor Devan said in Kochi on Wednesday said that he has no plans to withdraw from the contest for the post of president of the Association of Malayalam Movie Artistes (AMMA).

    He denied reports that he may withdraw his nomination to pave way for the election of a woman to the top post in the actors’ body. “I had hoped that senior actors Mohanlal or Mammootty wiouold lead the organisation. I had decided to file the nomination for the post of president only after Mr. Mohanlal decided that he will not contest,” he said.

    Mr. Devan said that the members of the association have the right to register their vote against people facing various allegations. He was responding to queries on the opposition by a section of the members against the nomination filed by actor Baburaj, who had faced allegations of sexual misconduct, for the post of general secretary.

    Actors like Dileep, Sididque, Edavela Babu, Vijay Babu had tendered their resignations earlier after they had faced such allegations, he said.

    On reports that actor Jagadeesh may withdraw his nomination for the post of president to pave way for the election of a woman candidate to the top post, Mr. Devan said that women had every right to assume leadership roles in any organisation. But it should not be at the mercy of men. It would be an insult to actor Swetha Menon, who is contesting for the post of president, if Mr. Jagadeesh has to withdraw from the race for her, he said.

    The actor stated that Mr. Mohanlal was deeply pained after he was attacked from various quarters after the release of the K. Hema committee report on the problems faced by women in Malayalam film industry.

    Published – July 30, 2025 06:19 pm IST

    Continue Reading

  • Israeli team develops low-cost 3D imaging tech to monitor crop health-Xinhua

    JERUSALEM, July 30 (Xinhua) — Israeli researchers created a low-cost method using ordinary video cameras to monitor plant health in 3D, the Hebrew University of Jerusalem said Wednesday in a statement.

    The technology, described in Computers and Electronics in Agriculture, analyzes video clips from multiple angles to build 3D models of crops like tomatoes, avoiding destructive sampling and expensive sensors, read the statement.

    Researchers captured more than 300 videos of greenhouse-grown dwarf tomatoes. Using motion analysis and machine learning, their system reconstructed leaf coverage with 96 percent accuracy, outperforming traditional 2D methods even when leaves overlapped or moved.

    The technology works with standard red-green-blue cameras, making it adaptable for global farms and greenhouses regardless of crop type, read the statement. ■

    Continue Reading

  • Integrative multi-omics data from early development to identify the genes and cell types underlying attention-deficit/hyperactivity disorder | BMC Psychiatry

    Integrative multi-omics data from early development to identify the genes and cell types underlying attention-deficit/hyperactivity disorder | BMC Psychiatry

  • Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387(10024):1240–50.

    Google Scholar 

  • Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015;1: 15020.

    Google Scholar 

  • Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237–48.

    Google Scholar 

  • Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. Lancet. 2020;395(10222):450–62.

    Google Scholar 

  • Sultan RS, Wang S, Crystal S, Olfson M. Antipsychotic treatment among youths with attention-deficit/hyperactivity disorder. JAMA Netw Open. 2019;2(7):e197850.

    Google Scholar 

  • Sultan RS, Liu SM, Hacker KA, Olfson M. Adolescents with attention-deficit/hyperactivity disorder: adverse behaviors and comorbidity. J Adolesc Health. 2021;68(2):284–91.

    Google Scholar 

  • Fischman AJ, Madras BK. The neurobiology of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1374–6.

    Google Scholar 

  • Sullivan PF, Daly MJ, O’Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012;13(8):537–51.

    CAS 

    Google Scholar 

  • Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019;24(4):562–75.

    CAS 

    Google Scholar 

  • Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019;51(1):63–75.

    CAS 

    Google Scholar 

  • Demontis D, Walters GB, Athanasiadis G, Walters R, Therrien K, Nielsen TT, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023;55(2):198–208.

    CAS 

    Google Scholar 

  • Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010;6(4): e1000888.

    Google Scholar 

  • Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337(6099):1190–5.

    CAS 

    Google Scholar 

  • Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol. 2012;30(11):1095–106.

    CAS 

    Google Scholar 

  • Gusev A, Mancuso N, Won H, Kousi M, Finucane HK, Reshef Y, et al. Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet. 2018;50(4):538–48.

    CAS 

    Google Scholar 

  • Wu Y, Bi R, Zeng C, Ma C, Sun C, Li J, et al. Identification of the primate-specific gene BTN3A2 as an additional schizophrenia risk gene in the MHC loci. EBioMedicine. 2019;44:530–41.

    CAS 

    Google Scholar 

  • Zhang C, Li X, Zhao L, Liang R, Deng W, Guo W, et al. Comprehensive and integrative analyses identify TYW5 as a schizophrenia risk gene. BMC Med. 2022;20(1):169.

    CAS 

    Google Scholar 

  • Wu Y, Yu XL, Xiao X, Li M, Li Y. Joint-tissue integrative analysis identified hundreds of schizophrenia risk genes. Mol Neurobiol. 2022;59(1):107–16.

    CAS 

    Google Scholar 

  • Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT, et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature. 2011;478(7370):519–23.

    CAS 

    Google Scholar 

  • Li M, Santpere G, Imamura Kawasawa Y, Evgrafov OV, Gulden FO, Pochareddy S, et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science. 2018;362(6420): eaat7615.

    CAS 

    Google Scholar 

  • Silbereis JC, Pochareddy S, Zhu Y, Li M, Sestan N. The cellular and molecular landscapes of the developing human central nervous system. Neuron. 2016;89(2):248–68.

    CAS 

    Google Scholar 

  • Polioudakis D, de la Torre-Ubieta L, Langerman J, Elkins AG, Shi X, Stein JL, et al. A single-cell transcriptomic atlas of human neocortical development during mid-gestation. Neuron. 2019;103(5):785–801. e8.

    CAS 

    Google Scholar 

  • Pedersen CB, Bybjerg-Grauholm J, Pedersen MG, Grove J, Agerbo E, Baekvad-Hansen M, et al. The iPSYCH2012 case-cohort sample: new directions for unravelling genetic and environmental architectures of severe mental disorders. Mol Psychiatry. 2018;23(1):6–14.

    CAS 

    Google Scholar 

  • Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015;47(5):435–44.

    CAS 

    Google Scholar 

  • O’Brien HE, Hannon E, Hill MJ, Toste CC, Robertson MJ, Morgan JE, et al. Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders. Genome Biol. 2018;19(1):194.

    Google Scholar 

  • Qi T, Wu Y, Fang H, Zhang F, Liu S, Zeng J, et al. Genetic control of RNA splicing and its distinct role in complex trait variation. Nat Genet. 2022;54(9):1355–63.

    CAS 

    Google Scholar 

  • Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S, et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature. 2017;546(7658):370–5.

    CAS 

    Google Scholar 

  • Jerber J, Seaton DD, Cuomo ASE, Kumasaka N, Haldane J, Steer J, et al. Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation. Nat Genet. 2021;53(3):304–12.

    CAS 

    Google Scholar 

  • Fujita M, Gao Z, Zeng L, McCabe C, White CC, Ng B, et al. Cell subtype-specific effects of genetic variation in the Alzheimer’s disease brain. Nat Genet. 2024;56(4):605–14.

    CAS 

    Google Scholar 

  • Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious orders study and rush memory and aging project. J Alzheimers Dis. 2018;64(s1):S161-89.

    Google Scholar 

  • Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, et al. Comprehensive functional genomic resource and integrative model for the human brain. Science. 2018;362(6420): eaat8464.

    CAS 

    Google Scholar 

  • Darmanis S, Sloan SA, Zhang Y, Enge M, Caneda C, Shuer LM, et al. A survey of human brain transcriptome diversity at the single cell level. Proc Natl Acad Sci USA. 2015;112(23):7285–90.

    CAS 

    Google Scholar 

  • Lake BB, Ai R, Kaeser GE, Salathia NS, Yung YC, Liu R, et al. Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain. Science. 2016;352(6293):1586–90.

    CAS 

    Google Scholar 

  • Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481–7.

    CAS 

    Google Scholar 

  • 1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.

    Google Scholar 

  • Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, Noble JA, et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet. 2013;9(11):e1003926.

    Google Scholar 

  • Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh PR, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet. 2015;47(11):1228–35.

    CAS 

    Google Scholar 

  • Finucane HK, Reshef YA, Anttila V, Slowikowski K, Gusev A, Byrnes A, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat Genet. 2018;50(4):621–9.

    CAS 

    Google Scholar 

  • de Leeuw CA, Mooij JM, Heskes T, Posthuma D. Magma: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11(4):e1004219.

    Google Scholar 

  • Trevino AE, Muller F, Andersen J, Sundaram L, Kathiria A, Shcherbina A, et al. Chromatin and gene-regulatory dynamics of the developing human cerebral cortex at single-cell resolution. Cell. 2021;184(19):5053–e6923.

    CAS 

    Google Scholar 

  • Bryois J, Skene NG, Hansen TF, Kogelman LJA, Watson HJ, Liu Z, et al. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease. Nat Genet. 2020;52(5):482–93.

    CAS 

    Google Scholar 

  • Olislagers M, Rademaker K, Adan RAH, Lin BD, Luykx JJ. Comprehensive analyses of RNA-seq and genome-wide data point to enrichment of neuronal cell type subsets in neuropsychiatric disorders. Mol Psychiatry. 2022;27(2):947–55.

    CAS 

    Google Scholar 

  • Cameron D, Mi D, Vinh NN, Webber C, Li M, Marin O, et al. Single-nuclei RNA sequencing of 5 regions of the human prenatal brain implicates developing neuron populations in genetic risk for schizophrenia. Biol Psychiatry. 2023;93(2):157–66.

    CAS 

    Google Scholar 

  • Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics Consortium, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291–5.

    CAS 

    Google Scholar 

  • de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. Advancing the understanding of autism disease mechanisms through genetics. Nat Med. 2016;22(4):345–61.

    Google Scholar 

  • Gandal MJ, Leppa V, Won H, Parikshak NN, Geschwind DH. The road to precision psychiatry: translating genetics into disease mechanisms. Nat Neurosci. 2016;19(11):1397–407.

    CAS 

    Google Scholar 

  • Graham AM, Marr M, Buss C, Sullivan EL, Fair DA. Understanding vulnerability and adaptation in early brain development using network neuroscience. Trends Neurosci. 2021;44(4):276–88.

    CAS 

    Google Scholar 

  • Zhou L, Zhou Y, Hang J, Wan R, Lu G, Yan C, et al. Crystal structure and biochemical analysis of the heptameric Lsm1-7 complex. Cell Res. 2014;24(4):497–500.

    CAS 

    Google Scholar 

  • Montemayor EJ, Didychuk AL, Yake AD, Sidhu GK, Brow DA, Butcher SE. Architecture of the U6 snRNP reveals specific recognition of 3’-end processed U6 snRNA. Nat Commun. 2018;9(1): 1749.

    Google Scholar 

  • Krausova M, Stanek D. SnRNP proteins in health and disease. Semin Cell Dev Biol. 2018;79:92–102.

    CAS 

    Google Scholar 

  • Jutzi D, Akinyi MV, Mechtersheimer J, Frilander MJ, Ruepp MD. The emerging role of minor intron splicing in neurological disorders. Cell Stress. 2018;2(3):40–54.

    Google Scholar 

  • Derksen A, Shih HY, Forget D, Darbelli L, Tran LT, Poitras C, et al. Variants in LSM7 impair LSM complexes assembly, neurodevelopment in zebrafish and may be associated with an ultra-rare neurological disease. HGG Adv. 2021;2(3):100034.

    CAS 

    Google Scholar 

  • Ferretti MB, Ghalei H, Ward EA, Potts EL, Karbstein K. Rps26 directs mRNA-specific translation by recognition of Kozak sequence elements. Nat Struct Mol Biol. 2017;24(9):700–7.

    CAS 

    Google Scholar 

  • Farrar JE, Vlachos A, Atsidaftos E, Carlson-Donohoe H, Markello TC, Arceci RJ, et al. Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood. 2011;118(26):6943–51.

    CAS 

    Google Scholar 

  • Skene NG, Bryois J, Bakken TE, Breen G, Crowley JJ, Gaspar HA, et al. Genetic identification of brain cell types underlying schizophrenia. Nat Genet. 2018;50(6):825–33.

    CAS 

    Google Scholar 

  • Sudre G, Gildea DE, Shastri GG, Sharp W, Jung B, Xu Q, et al. Mapping the cortico-striatal transcriptome in attention deficit hyperactivity disorder. Mol Psychiatry. 2023;28(2):792–800.

    CAS 

    Google Scholar 

  • Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry. 2004;9(11):984–97.

    CAS 

    Google Scholar 

  • Chatterjee M, Saha S, Shom S, Dutta N, Sinha S, Mukhopadhyay K. Glutamate receptor genetic variants affected peripheral glutamatergic transmission and treatment induced improvement of Indian ADHD probands. Sci Rep. 2023;13(1):19922.

    CAS 

    Google Scholar 

  • He J, Li J, Wei Y, He Z, Liu J, Yuan N, et al. Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naive patients with treatment-resistant schizophrenia. BMC Psychiatry. 2024;24(1): 248.

    CAS 

    Google Scholar 

  • de Klein N, Tsai EA, Vochteloo M, Baird D, Huang Y, Chen CY, et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat Genet. 2023;55(3):377–88.

    Google Scholar 

  • Bhaduri A, Sandoval-Espinosa C, Otero-Garcia M, Oh I, Yin R, Eze UC, et al. An atlas of cortical arealization identifies dynamic molecular signatures. Nature. 2021;598(7879):200–4.

    CAS 

    Google Scholar 

    • Continue Reading

  • DC’s Silver Lyan introduces new menu – Drinks International

    DC’s Silver Lyan introduces new menu – Drinks International

    The new menu builds on the bar’s approach of cultural exchange, with 17 signature cocktails including Silver Lyan classics.

    The menu is split into four chapters, each featuring four cocktails. Culture and Media explores the knock-on effects of cultural expression, Law and Government is the intersection of human predictability with the structures of government, Conflict is inspired by the unintended consequences of human disputes and Silver Classics are guest favourites from previous menus.

    Owner of Silver Lyan, Ryan Chetiyawardana, said: “Spending time in the US, the birthplace of the cocktail, has always been super inspiring to us, and opening Silver Lyan here five years ago felt like the start of something really exciting, and through the years has allowed us to explore really exciting new ground. DC is full of stories that go way beyond food and drink, from music to activism to art, and so much more, and those stories have fuelled our team from day one. That’s what ‘The Butterfly Effect’ is all about; learning, sharing, and growing together, both in the bar and beyond, and exploring how tiny shifts can spark big changes.”

    Serves include the It’s Alive! 75, from Culture and Media, made with Patrón Reposado, reanimated berry Madeira, acorns, pandan absinthe, and Champagne, drawing on the chain of events that led to Mary Shelley writing Frankenstein. In Conflict, Operation Mindf*ck is a blend of Ocho reposado, woolly calvados, mesquite carrot vermouth, garden peas, secret bitters, portraying the story of science fiction writer Kerry Thornley and Playboy editor Robert Wilson, who jokingly blamed events on the Illuminati as a form of culture jamming.

    Of the classics, highlights include the Silver Apple Martini, with Belvedere 10, clarified green apple, Capreolus ‘1000 Trees’ and bisongrass. The bar also offers takes on classic shots, including Tots & Shots, available in three blends and served with American classic tater tots, and Jello Shots, available with Aperol Spritz or Hugo Spritz and served with a champagne chaser. 

    Continue Reading

  • Pakistan’s exports to Afghanistan witness increase in FY 2025-Xinhua

    ISLAMABAD, July 30 (Xinhua) — Pakistan’s export of goods and services to Afghanistan witnessed an increase of 38.68 percent in fiscal year 2025, which runs from July 2024 to June 2025, compared to the same period of the last fiscal year, officials from the State Bank of Pakistan (SBP) said on Wednesday.

    The overall exports to Afghanistan were recorded at 773.89 million U.S. dollars in fiscal year 2025, up from 558.03 million dollars in fiscal year 2024, the SBP officials said.

    On a year-on-year basis, the exports to Afghanistan went up by 8.24 percent from 46.41 million dollars in June 2024 to 50.23 million dollars in June 2025.

    Meanwhile, the imports from Afghanistan into Pakistan in fiscal year 2025 were recorded at 25.90 million dollars, compared to 11.96 million dollars in fiscal year 2024. ■

    Continue Reading

  • Meta’s Key to Workplace Engagement

    Meta’s Key to Workplace Engagement

    The Science Behind VR’s Perfect Session Length

    As someone who’s witnessed countless enterprises struggle with VR adoption rates, I’m genuinely excited about Meta’s latest developer insights that could finally unlock widespread workplace implementation. If you’re an innovation leader grappling with low engagement in your VR training programs or wondering why employees aren’t embracing immersive collaboration tools, this breakthrough research offers the answers you’ve been seeking.

    Meta has identified what they call the “Goldilocks zone” for VR sessions—a 20-40 minute window that’s not too short to deliver meaningful value, not too long to cause fatigue, and just right for sustained engagement. This isn’t just theoretical speculation; it’s based on extensive user research that reveals why so many enterprise VR initiatives have failed to gain traction.

    Why Traditional Approaches to VR Training Fall Short

    The revelation strikes at the heart of a persistent problem in workplace technology adoption. Meta’s research shows that sessions lasting less than 15-20 minutes are viewed as significantly less enjoyable, with users reporting high friction around the physical setup and anticipation of post-session work. This explains why brief, mobile-style interactions simply don’t translate to VR environments.

    “Due to this friction, sessions must be long enough to deliver on a satisfying amount of progress, engagement or entertainment to validate the decision to engage with VR. That threshold is 15-20 minutes for most users.”

    Think about your current employee training programs. How many times have you invested in VR solutions only to see engagement drop off after the initial novelty wears off? The issue isn’t with the technology itself—it’s with session design that doesn’t account for the unique constraints of immersive experiences.

    The Physical Reality of Extended Reality

    What makes this research particularly valuable for enterprise decision-makers is its honest acknowledgment of current form factor limitations. Meta doesn’t sugarcoat the challenges: long VR sessions can be physically uncomfortable, cause eye strain and motion sickness, require social isolation, and are limited by battery life. These aren’t problems to ignore—they’re design constraints to work within.

    For workplace applications, this means rethinking how we structure everything from safety training simulations to collaborative design reviews. Instead of hour-long immersive experiences that leave employees exhausted, the sweet spot lies in creating meaningful 20-40 minute sessions that chain together shorter, focused activities.

    Practical Applications for Enterprise VR

    Consider how this translates to real workplace scenarios. A manufacturing safety training program could break complex procedures into 10-15 minute modules that employees complete over 2-3 sessions, rather than overwhelming them with a single lengthy experience. Each module delivers immediate value while building toward comprehensive competency.

    The research highlights successful examples from gaming that translate perfectly to enterprise use. Take the core loop structure Meta describes for “Population: ONE”—players complete meaningful objectives in 10-15 minutes, with clear progression and natural stopping points. This same principle applies whether you’re designing virtual sales presentations, collaborative architectural walkthroughs, or immersive customer service training.

    Building Enterprise-Ready VR Experiences

    Meta’s recommendations offer a blueprint for enterprise VR success. The key principles include delivering core value within the first 20 minutes, focusing on shorter loops that chain together, building in regular breaks every 10-15 minutes, and creating easy entry and exit points.

    For business leaders, this means your VR investments should prioritize experiences that respect these natural usage patterns rather than fighting against them. Auto-save functionality becomes crucial when employees need to step away for meetings or calls. Progress indicators help users decide whether to continue or take a strategic break.

    The Future of Workplace Immersion

    This research represents more than just optimization guidelines—it’s a roadmap for making VR a practical, sustainable part of the modern workplace. As form factors continue to evolve and improve, these principles will likely expand the Goldilocks zone, but for now, they provide a scientific foundation for designing experiences that actually get used.

    The implications extend beyond individual training sessions to entire organizational change management strategies. When you can consistently deliver satisfying 20-40 minute VR experiences that employees genuinely enjoy, you’re not just improving training outcomes—you’re building cultural acceptance of immersive technologies that will define the future of work.

    Imagine walking into your next quarterly review knowing that your VR training programs have 90% completion rates instead of 30%, or that your remote collaboration sessions are actually preferred over traditional video calls. With spatial computing becoming increasingly sophisticated, the companies that master these engagement principles now will have a significant competitive advantage as immersive workplaces become the norm.

    The line between the physical and virtual workplace continues to blur, and Meta’s research provides the scientific foundation for ensuring that transition enhances rather than hinders human productivity and satisfaction. Will your organization be ready to leverage these insights, or will you continue struggling with VR adoption challenges that have clear, data-driven solutions?

    Ready to transform your approach to workplace VR? Join our vibrant community of 2000+ XR professionals on LinkedIn to dive deeper into these implementation strategies and share your own experiences with immersive workplace technologies. Don’t miss our weekly insights—subscribe to our newsletter for the most crucial XR industry developments that will shape your digital transformation journey.

    Continue Reading

  • Liverpool 3-1 Yokohama FM (Jul 30, 2025) Game Analysis

    Liverpool 3-1 Yokohama FM (Jul 30, 2025) Game Analysis

    Florian Wirtz scored his first goal for Liverpool as the Premier League champions came from behind to beat J1 League side Yokohama F. Marinos 3-1 in a preseason friendly in Japan.

    There had initially been concern about whether the game would go ahead after a tsunami warning was issued following an 8.8 magnitude earthquake off the eastern coast of Russia in the early hours of Wednesday morning.

    However, it was deemed safe for the match to take place, with Wirtz and teenage duo Trey Nyoni and Rio Ngumoha scoring for the visitors at the Nissan Stadium after Asahi Uenaka had given Yokohama the lead early in the second half.

    Striker Hugo Ekitike made his debut for Liverpool following his £69million ($92.1m) move from Eintracht Frankfurt and came close to putting Arne Slot’s ahead with an audacious back-heel in the 25th minute.

    Cody Gakpo hit the post for Liverpool while Giorgi Mamardashvili — deputising for Alisson Becker, who has returned to Brazil for person reasons — made an excellent save to deny Jun Amano before the break.

    The hosts took the lead after Uenaka applied the finishing touch to a slick move early in the second half.

    Florian Wirtz scored the equaliser for Liverpool before they went on to win 3-1 in Japan.

    Andrew Powell/Liverpool FC via Getty Images

    However, Liverpool bounced back through Wirtz, who finished emphatically from close range after some fine work from Mohamed Salah on the right wing. Midfielder Nyoni, 18, then found the back of the net with an acrobatic finish following a superb cross from Jeremie Frimpong.

    Fellow teenager Ngumoha, 16, rounded off a strong second-half performance with a stunning individual strike three minutes from time.

    The victory completes Liverpool’s preseason tour of the Far East, with the Reds having suffered a 4-2 defeat to AC Milan on Saturday. They will now return to the UK where they will host Athletic Club in a double-header of friendlies at Anfield on Aug. 4.

    Continue Reading

  • The 0.05% RNA Process That Makes Cancer Self-Destruct

    The 0.05% RNA Process That Makes Cancer Self-Destruct

    Australian researchers have discovered a promising new strategy to suppress the growth of aggressive and hard-to-treat cancers by targeting a specialized molecular process known as ‘minor splicing’.

    Published in EMBO Reports, the study shows that blocking minor splicing can markedly slow tumor growth in liver, lung and stomach cancers, while leaving healthy cells largely unharmed.

    The research in animal models and human cells, from Australian medical research institute WEHI, demonstrates the potential of this strategy to target cancers driven by mutations in common cancer-causing genes.

    At a glance

    • New research shows that targeting minor splicing significantly reduces tumor growth in liver, lung and gastric cancers.
    • The strategy is particularly effective for cancers driven by KRAS mutations, which are among the most common genetic changes found in cancer.
    • The study demonstrates the therapeutic potential of minor splicing inhibition across diverse cancer models.

    Why minor splicing matters

    Splicing is how cells turn long strands of RNA into shorter pieces called messenger RNA, which provide the template for the production of proteins.

    While major splicing carries out 99.5% of this work, minor splicing is an indispensable process for the remaining 0.05% of genes, affecting about 700 of the 20,000 genes in the human genome.

    The new research reveals that blocking minor splicing causes the accumulation of DNA damage in cancer cells and activates a key tumor suppressor pathway that leads to cell death. Remarkably, healthy cells are largely unaffected.

    Although it affects only a small sub-set of genes, minor splicing is crucial for the correct expression of genes that drive cell growth and division – making it a potential Achilles’ heel for cancer cells.

    Importantly, many of these genes are commonly hijacked by cancers driven by KRAS mutations, which are among the most frequent genetic changes found in solid tumors.

    WEHI laboratory head Professor Joan Heath said scientists have long known that KRAS is central to many aggressive cancers but have struggled to turn that knowledge into broadly effective treatments.

    “KRAS mutations come in a variety of flavors, making them extremely hard to treat, so even with decades of scientific effort there has been only limited progress so far,” Prof Heath said.

    “But our approach is different. Instead of trying to target specific mutations that may only apply to a subset of patients, we’re disrupting a fundamental process that these fast-growing cancers rely on.

    “This research offers a new way to tackle a problem that’s long resisted conventional approaches, with the potential to help a much wider group of patients.”

    Striking result reveals path towards new treatments

    Using zebrafish and mouse models, as well as human lung cancer cells, the WEHI-led research is the first to demonstrate the impact of inhibiting minor splicing in in vivo models of solid tumours.

    The study found reducing the activity of a protein encoded by the RNPC3 gene – an essential component of the minor splicing machinery – significantly slows tumor growth in liver, lung and stomach cancers.

    “Just by halving the amount of this protein, we were able to significantly reduce tumor burden,” said Dr Karen Doggett, first author of the study.

    “That’s a striking result, especially given how resilient these cancers usually are.”

    The study also revealed that disrupting minor splicing triggers the p53 tumor suppressor pathway, a critical defense mechanism in the body’s fight against cancer.

    Dubbed the ‘guardian of the genome’, the p53 protein responds to DNA damage by stalling cell division, initiating DNA repair or triggering cell death. This well-known pathway is frequently mutated or disabled in many cancers, allowing these cells to grow unchecked.

    “Blocking minor splicing leads to DNA damage and activates this critical defensive response, which means cancers with a functional p53 pathway are likely to be especially vulnerable to this strategy,” Dr Doggett said.

    “This opens the door to treatments that could be both more effective and less toxic, offering hope for patients with aggressive cancers that currently have limited options.”

    Drug discovery collaboration

    To search for compounds that might inhibit minor splicing, the research team turned to the National Drug Discovery Centre headquartered at WEHI, with a screen of over 270,000 drug-like molecules identifying several promising hits.

    “We’ve validated minor splicing as a compelling therapeutic target – now the challenge is to develop a drug compound that can safely and effectively inhibit it,” Prof Heath said.

    The research draws on WEHI’s deep expertise in gene discovery and cancer biology, showcasing the power of collaboration across multiple labs and technologies.

    “One of the strengths of this study is the breadth of models and tumor types we used,” Prof Heath said.

    “We didn’t just test one kind of cancer or use one analysis method. This diversity in our approach gives us confidence that our strategy could be relevant across many forms of cancer, and not just in a narrow set of conditions.”

    The research was supported by the National Health and Medical Research Council of Australia (NHMRC), Ludwig Institute for Cancer Research and the National Institute of Neurological Disorders and Stroke.

    The study, “Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers,” is published in EMBO Reports.

    Continue Reading